Transcriptional	O
activity	O
of	O
core	B-protein
binding	I-protein
factor-alpha	I-protein
(	I-protein
AML1	I-protein
)	I-protein
and	I-protein
beta	I-protein
subunits	O
on	O
murine	B-DNA
leukemia	I-DNA
virus	I-DNA
enhancer	I-DNA
cores	I-DNA
.	O

Core	B-protein
binding	I-protein
factor	I-protein
(	O
CBF	B-protein
)	O
,	O
also	O
known	O
as	O
polyomavirus	B-protein
enhancer-binding	I-protein
protein	I-protein
2	I-protein
and	O
SL3	B-protein
enhancer	I-protein
factor	I-protein
1	I-protein
,	O
is	O
a	O
mammalian	B-protein
transcription	I-protein
factor	I-protein
that	O
binds	O
to	O
an	O
element	O
termed	O
the	O
core	O
within	O
the	O
enhancers	B-DNA
of	O
the	O
murine	O
leukemia	O
virus	O
family	O
of	O
retroviruses	O
.	O

The	O
core	B-DNA
elements	I-DNA
of	O
the	O
SL3	O
virus	O
are	O
important	O
genetic	O
determinants	O
of	O
the	O
ability	O
of	O
this	O
virus	O
to	O
induce	O
T-cell	O
lymphomas	O
and	O
the	O
transcriptional	O
activity	O
of	O
the	O
viral	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
in	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

CBF	B-protein
consists	O
of	O
two	O
subunits	O
,	O
a	O
DNA	B-protein
binding	I-protein
subunit	I-protein
,	O
CBF	B-protein
alpha	I-protein
,	O
and	O
a	O
second	O
subunit	O
,	O
CBF	B-protein
beta	I-protein
,	O
that	O
stimulates	O
the	O
DNA	O
binding	O
activity	O
of	O
CBF	B-protein
alpha	I-protein
.	O

One	O
of	O
the	O
genes	O
that	O
encodes	O
a	O
CBF	B-protein
alpha	I-protein
subunit	I-protein
is	O
AML1	B-protein
,	O
also	O
called	O
Cbf	B-protein
alpha	I-protein
2	I-protein
.	O

This	O
locus	O
is	O
rearranged	O
by	O
chromosomal	O
translocations	O
in	O
human	O
myeloproliferative	O
disorders	O
and	O
leukemias	O
.	O

An	O
exogenously	O
expressed	O
Cbf	B-protein
alpha	I-protein
2-encoded	I-protein
subunit	I-protein
(	O
CBF	B-protein
alpha	I-protein
2-451	I-protein
)	O
stimulated	O
transcription	O
from	O
the	O
SL3	B-DNA
enhancer	I-DNA
in	O
P19	B-protein
and	O
HeLa	B-cell_line
cells	I-cell_line
.	O

Activity	O
was	O
mediated	O
through	O
the	O
core	B-DNA
elements	I-DNA
.	O

Three	O
different	O
isoforms	O
of	O
CBF	B-protein
beta	I-protein
were	O
also	O
tested	O
for	O
transcriptional	O
activity	O
on	O
the	O
SL3	B-DNA
enhancer	I-DNA
.	O

The	O
longest	O
form	O
,	O
CBF	B-protein
beta-187	I-protein
,	O
increased	O
the	O
transcriptional	O
stimulation	O
by	O
CBF	B-protein
alpha	I-protein
2-451	I-protein
twofold	O
in	O
HeLa	B-cell_line
cells	I-cell_line
,	O
although	O
it	O
had	O
no	O
effect	O
in	O
P19	B-cell_line
cells	I-cell_line
.	O

Transcriptional	O
activation	O
by	O
CBF	B-protein
beta	I-protein
required	O
binding	O
to	O
the	O
CBF	B-protein
alpha	I-protein
subunit	I-protein
,	O
as	O
a	O
form	O
of	O
CBF	B-protein
beta	I-protein
that	O
lacked	O
binding	O
ability	O
,	O
CBF	B-protein
beta-148	I-protein
,	O
failed	O
to	O
increase	O
activity	O
.	O

These	O
results	O
indicated	O
that	O
at	O
least	O
in	O
certain	O
cell	O
types	O
,	O
the	O
maximum	O
activity	O
of	O
CBF	B-protein
required	O
both	O
subunits	O
.	O

They	O
also	O
provided	O
support	O
for	O
the	O
hypothesis	O
that	O
CBF	B-protein
is	O
a	O
factor	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
that	O
is	O
responsible	O
for	O
recognition	O
of	O
the	O
SL3	B-DNA
cores	I-DNA
.	O

We	O
also	O
examined	O
whether	O
CBF	B-protein
could	O
distinguish	O
a	O
1-bp	O
difference	O
between	O
the	O
enhancer	O
core	O
of	O
SL3	O
and	O
the	O
core	O
of	O
the	O
nonleukemogenic	O
virus	O
,	O
Akv	O
.	O

This	O
difference	O
strongly	O
affects	O
transcription	O
in	O
T	O
cells	O
and	O
leukemogenicity	O
of	O
SL3	B-DNA
.	O

However	O
,	O
no	O
combination	O
of	O
CBF	B-protein
alpha	I-protein
and	O
CBF	B-protein
beta	I-protein
subunits	O
that	O
we	O
tested	O
was	O
able	O
to	O
distinguish	O
the	O
1-bp	O
difference	O
in	O
transcription	O
assays	O
.	O

Thus	O
,	O
a	O
complete	O
understanding	O
of	O
how	O
T	B-cell_type
cells	I-cell_type
recognize	O
the	O
SL3	B-DNA
core	I-DNA
remains	O
to	O
be	O
elucidated	O
.	O

JournaL	NULL
or	NULL
VirRoLoGYy	NULL
,	NULL
May	NULL
1995	NULL
,	NULL
p.	NULL
2898-2906	NULL
0022-538	NULL
Copyright	NULL
©	NULL
1995	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

69	NULL
,	NULL
No	NULL
.	NULL

5	NULL
Transcriptional	NULL
Activity	NULL
of	NULL
Core	NULL
Binding	NULL
Factor	NULL
«	NULL
(	NULL
AML1	NULL
)	NULL
and	NULL
B	NULL
Subunits	NULL
on	NULL
Murine	NULL
Leukemia	NULL
Virus	NULL
Enhancer	NULL
Cores	NULL
ARI	NULL
L.	NULL
ZAIMAN	NULL
,	NULL
``	NULL
AMY	NULL
F.	NULL
LEWIS	NULL
,	NULL
``	NULL
BARBARA	NULL
E.	NULL
CRUTE	NULL
,	NULL
``	NULL
NANCY	NULL
A.	NULL
SPECK	NULL
,	NULL
``	NULL
anp	NULL
JACK	NULL
LENZ	NULL
!	NULL

**	NULL
Department	NULL
of	NULL
Molecular	NULL
Genetics	NULL
,	NULL
Albert	NULL
Einstein	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Bronx	NULL
,	NULL
New	NULL
York	NULL
10461	NULL
,	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Dartmouth	NULL
Medical	NULL
School	NULL
,	NULL
Hanover	NULL
,	NULL
New	NULL
Hampshire	NULL
03755	NULL
Received	NULL
29	NULL
July	NULL
1994/Accepted	NULL
9	NULL
February	NULL
1995	NULL
Core	NULL
binding	NULL
factor	NULL
(	NULL
CBF	NULL
)	NULL
,	NULL
also	NULL
known	NULL
as	NULL
polyomavirus	NULL
enhancer-binding	NULL
protein	NULL
2	NULL
and	NULL
SL3	NULL
enhancer	NULL
factor	NULL
1	NULL
,	NULL
is	NULL
a	NULL
mammalian	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
an	NULL
element	NULL
termed	NULL
the	NULL
core	NULL
within	NULL
the	NULL
enhancers	NULL
of	NULL
the	NULL
murine	NULL
leukemia	NULL
virus	NULL
family	NULL
of	NULL
retroviruses	NULL
.	NULL

The	NULL
core	NULL
elements	NULL
of	NULL
the	NULL
SL3	NULL
virus	NULL
are	NULL
important	NULL
genetic	NULL
determinants	NULL
of	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
virus	NULL
to	NULL
induce	NULL
T-cell	NULL
lymphomas	NULL
and	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
viral	NULL
long	NULL
terminal	NULL
repeat	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

CBF	NULL
consists	NULL
of	NULL
two	NULL
subunits	NULL
,	NULL
a	NULL
DNA	NULL
binding	NULL
subunit	NULL
,	NULL
CBF	NULL
«	NULL
,	NULL
and	NULL
a	NULL
second	NULL
subunit	NULL
,	NULL
CBF	NULL
$	NULL
,	NULL
that	NULL
stimulates	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
CBF	NULL
«	NULL
.	NULL

One	NULL
of	NULL
the	NULL
genes	NULL
that	NULL
encodes	NULL
a	NULL
CBF	NULL
a	NULL
subunit	NULL
is	NULL
4ML1	NULL
,	NULL
also	NULL
called	NULL
Chfo2	NULL
.	NULL

This	NULL
locus	NULL
is	NULL
rearranged	NULL
by	NULL
chromosomal	NULL
translocations	NULL
in	NULL
human	NULL
myeloproliferative	NULL
disorders	NULL
and	NULL
leukemias	NULL
.	NULL

An	NULL
exogenously	NULL
expressed	NULL
Chfo2-encoded	NULL
subunit	NULL
(	NULL
CBFo2-451	NULL
)	NULL
stimulated	NULL
transcription	NULL
from	NULL
the	NULL
SL3	NULL
enhancer	NULL
in	NULL
P19	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

Activity	NULL
was	NULL
mediated	NULL
through	NULL
the	NULL
core	NULL
elements	NULL
.	NULL

Three	NULL
different	NULL
isoforms	NULL
of	NULL
CBF	NULL
B	NULL
were	NULL
also	NULL
tested	NULL
for	NULL
transcriptional	NULL
activity	NULL
on	NULL
the	NULL
SL3	NULL
enhancer	NULL
.	NULL

The	NULL
longest	NULL
form	NULL
,	NULL
CBF	NULL
3-187	NULL
,	NULL
increased	NULL
the	NULL
transcriptional	NULL
stimulation	NULL
by	NULL
CBF	NULL
«	NULL
2-451	NULL
twofold	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
although	NULL
it	NULL
had	NULL
no	NULL
effect	NULL
in	NULL
P19	NULL
cells	NULL
.	NULL

Transcriptional	NULL
activation	NULL
by	NULL
CBF	NULL
BB	NULL
required	NULL
binding	NULL
to	NULL
the	NULL
CBF	NULL
«	NULL
subunit	NULL
,	NULL
as	NULL
a	NULL
form	NULL
of	NULL
CBF	NULL
B	NULL
that	NULL
lacked	NULL
binding	NULL
ability	NULL
,	NULL
CBF	NULL
B-148	NULL
,	NULL
failed	NULL
to	NULL
increase	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
at	NULL
least	NULL
in	NULL
certain	NULL
cell	NULL
types	NULL
,	NULL
the	NULL
maximum	NULL
activity	NULL
of	NULL
CBF	NULL
required	NULL
both	NULL
subunits	NULL
.	NULL

They	NULL
also	NULL
provided	NULL
support	NULL
for	NULL
the	NULL
hypothesis	NULL
that	NULL
CBF	NULL
is	NULL
a	NULL
factor	NULL
in	NULL
T	NULL
lymphocytes	NULL
that	NULL
is	NULL
responsible	NULL
for	NULL
recognition	NULL
of	NULL
the	NULL
SL3	NULL
cores	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
whether	NULL
CBF	NULL
could	NULL
distinguish	NULL
a	NULL
1-bp	NULL
difference	NULL
between	NULL
the	NULL
enhancer	NULL
core	NULL
of	NULL
SL3	NULL
and	NULL
the	NULL
core	NULL
of	NULL
the	NULL
nonleukemogenic	NULL
virus	NULL
,	NULL
Akv	NULL
.	NULL

This	NULL
difference	NULL
strongly	NULL
affects	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
leukemogenicity	NULL
of	NULL
SL3	NULL
.	NULL

However	NULL
,	NULL
no	NULL
combination	NULL
of	NULL
CBF	NULL
«	NULL
and	NULL
CBF	NULL
(	NULL
subunits	NULL
that	NULL
we	NULL
tested	NULL
was	NULL
able	NULL
to	NULL
distinguish	NULL
the	NULL
1-bp	NULL
difference	NULL
in	NULL
transcription	NULL
assays	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
complete	NULL
understanding	NULL
of	NULL
how	NULL
T	NULL
cells	NULL
recognize	NULL
the	NULL
SL3	NULL
core	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

Core	NULL
binding	NULL
factor	NULL
(	NULL
CBF	NULL
)	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
initially	NULL
identified	NULL
as	NULL
a	NULL
cellular	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
enhancers	NULL
of	NULL
several	NULL
viruses	NULL
and	NULL
cellular	NULL
genes	NULL
.	NULL

CBF	NULL
binds	NULL
to	NULL
an	NULL
element	NULL
termed	NULL
the	NULL
enhancer	NULL
core	NULL
(	NULL
4	NULL
,	NULL
18	NULL
,	NULL
41	NULL
,	NULL
46	NULL
,	NULL
48	NULL
,	NULL
51	NULL
)	NULL
within	NULL
the	NULL
genomes	NULL
of	NULL
mammalian	NULL
type	NULL
C	NULL
retroviruses	NULL
(	NULL
10	NULL
)	NULL
.	NULL

It	NULL
also	NULL
binds	NULL
to	NULL
similar	NULL
elements	NULL
within	NULL
the	NULL
enhancers	NULL
of	NULL
polyomavirus	NULL
and	NULL
several	NULL
cellular	NULL
genes	NULL
,	NULL
including	NULL
those	NULL
encoding	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
B	NULL
,	NULL
y	NULL
,	NULL
and	NULL
8	NULL
chains	NULL
,	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
,	NULL
CD3-£	NULL
,	NULL
and	NULL
CD3-8	NULL
,	NULL
interleukin-3	NULL
,	NULL
and	NULL
myeloperoxidase	NULL
(	NULL
6	NULL
,	NULL
14	NULL
,	NULL
15	NULL
,	NULL
17	NULL
,	NULL
35	NULL
,	NULL
37	NULL
,	NULL
45	NULL
,	NULL
49	NULL
,	NULL
51	NULL
)	NULL
.	NULL

CBF	NULL
is	NULL
also	NULL
called	NULL
polyomavirus	NULL
enhancer-binding	NULL
protein	NULL
2	NULL
(	NULL
PEBP2	NULL
)	NULL
(	NULL
17	NULL
)	NULL
,	NULL
SL3	NULL
enhancer	NULL
factor	NULL
1	NULL
(	NULL
46	NULL
)	NULL
,	NULL
and	NULL
SL3/Akyv	NULL
core	NULL
binding	NULL
factor	NULL
(	NULL
4	NULL
)	NULL
.	NULL

CBF	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
heterologous	NULL
subunits	NULL
,	NULL
CBF	NULL
a	NULL
and	NULL
CBF	NULL
B.	NULL
cDNAs	NULL
encoding	NULL
both	NULL
subunits	NULL
of	NULL
CBF	NULL
have	NULL
recently	NULL
been	NULL
cloned	NULL
.	NULL

There	NULL
are	NULL
at	NULL
least	NULL
three	NULL
related	NULL
mammalian	NULL
genes	NULL
that	NULL
encode	NULL
CBF	NULL
«	NULL
subunits	NULL
.	NULL

One	NULL
,	NULL
called	NULL
AML	NULL
J	NULL
or	NULL
Chfo2	NULL
,	NULL
was	NULL
originally	NULL
cloned	NULL
from	NULL
a	NULL
common	NULL
translocation	NULL
breakpoint	NULL
in	NULL
patients	NULL
with	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
(	NULL
AML	NULL
)	NULL
of	NULL
the	NULL
M2	NULL
subtype	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
reciprocal	NULL
8	NULL
;	NULL
21	NULL
translocation	NULL
results	NULL
in	NULL
the	NULL
5	NULL
'	NULL
portion	NULL
of	NULL
AML	NULL
1	NULL
being	NULL
fused	NULL
in	NULL
frame	NULL
to	NULL
sequences	NULL
on	NULL
chromosome	NULL
8	NULL
termed	NULL
ETO	NULL
or	NULL
MTGS8	NULL
(	NULL
9	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
3	NULL
;	NULL
21	NULL
translocations	NULL
that	NULL
occur	NULL
in	NULL
therapy-related	NULL
AML	NULL
,	NULL
myelodysplastic	NULL
syndrome	NULL
,	NULL
or	NULL
blast	NULL
crisis	NULL
of	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
were	NULL
also	NULL
found	NULL
to	NULL
result	NULL
in	NULL
rearrangments	NULL
at	NULL
the	NULL
AML	NULL
J	NULL
locus	NULL
(	NULL
31	NULL
,	NULL
38	NULL
)	NULL
.	NULL

One	NULL
type	NULL
of	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
results	NULL
in	NULL
the	NULL
5	NULL
'	NULL
portion	NULL
of	NULL
AMLI	NULL
being	NULL
fused	NULL
to	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
ribosomal	NULL
protein	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Molecular	NULL
Genetics	NULL
,	NULL
Albert	NULL
Einstein	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
1300	NULL
Morris	NULL
Park	NULL
Ave.	NULL
,	NULL
Bronx	NULL
,	NULL
NY	NULL
10461	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
718	NULL
)	NULL
430-3715	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
718	NULL
)	NULL
430-8778	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
lenz	NULL
@	NULL
aecom.yu.edu	NULL
.	NULL

2898	NULL
(	NULL
EAP/L22	NULL
)	NULL
on	NULL
chromosome	NULL
3	NULL
such	NULL
that	NULL
EAP	NULL
sequences	NULL
in	NULL
the	NULL
fusion	NULL
protein	NULL
are	NULL
read	NULL
out	NULL
of	NULL
frame	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Another	NULL
type	NULL
of	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
results	NULL
in	NULL
fusion	NULL
of	NULL
the	NULL
5	NULL
'	NULL
portion	NULL
of	NULL
AML	NULL
]	NULL
to	NULL
the	NULL
entire	NULL
EVI-1	NULL
coding	NULL
sequence	NULL
(	NULL
26	NULL
)	NULL
.	NULL

cDNA	NULL
clones	NULL
encoding	NULL
the	NULL
mouse	NULL
homolog	NULL
of	NULL
AML1	NULL
,	NULL
called	NULL
PEBP2aB	NULL
,	NULL
were	NULL
shown	NULL
to	NULL
encode	NULL
proteins	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
polyomavirus	NULL
enhancer	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
human	NULL
AML	NULL
protein	NULL
was	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
enhancer	NULL
core	NULL
consensus	NULL
sequence	NULL
(	NULL
25	NULL
,	NULL
34	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirmed	NULL
that	NULL
AMLI/PEBP2a	NULL
«	NULL
B	NULL
encodes	NULL
a	NULL
CBF	NULL
a	NULL
subunit	NULL
.	NULL

Two	NULL
additional	NULL
genes	NULL
encode	NULL
CBF	NULL
a	NULL
subunits	NULL
:	NULL
Chfo	NULL
]	NULL
(	NULL
Pebpa2a	NULL
,	NULL
AML	NULL
3	NULL
)	NULL
and	NULL
Cbfo3	NULL
(	NULL
Pebpo2ec	NULL
,	NULL
AML2	NULL
)	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
20	NULL
,	NULL
34	NULL
,	NULL
52	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
three	NULL
CBF	NULL
«	NULL
-subunit	NULL
genes	NULL
encodes	NULL
a	NULL
stretch	NULL
of	NULL
128	NULL
amino	NULL
acids	NULL
called	NULL
the	NULL
Runt	NULL
domain	NULL
that	NULL
is	NULL
highly	NULL
homologous	NULL
to	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
Drosophila	NULL
segmentation	NULL
pair-rule	NULL
gene	NULL
,	NULL
runt	NULL
(	NULL
8	NULL
,	NULL
9	NULL
,	NULL
16	NULL
,	NULL
34	NULL
)	NULL
.	NULL

The	NULL
Runt	NULL
domain	NULL
mediates	NULL
DNA	NULL
binding	NULL
(	NULL
16	NULL
,	NULL
25	NULL
,	NULL
34	NULL
)	NULL
.	NULL

As	NULL
a	NULL
result	NULL
of	NULL
alternative	NULL
splicing	NULL
,	NULL
multiple	NULL
forms	NULL
of	NULL
the	NULL
CBF	NULL
a	NULL
proteins	NULL
are	NULL
encoded	NULL
by	NULL
both	NULL
the	NULL
Chfa2	NULL
and	NULL
Cbfa	NULL
]	NULL
genes	NULL
(	NULL
2	NULL
,	NULL
16	NULL
,	NULL
34	NULL
)	NULL
.	NULL

A	NULL
third	NULL
gene	NULL
,	NULL
AML	NULL
2	NULL
or	NULL
Cbfa3	NULL
,	NULL
that	NULL
encodes	NULL
a	NULL
CBF	NULL
a	NULL
subunit	NULL
was	NULL
identified	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
sequence	NULL
homology	NULL
(	NULL
20	NULL
)	NULL
.	NULL

While	NULL
the	NULL
transcriptional	NULL
properties	NULL
of	NULL
CBF	NULL
a	NULL
have	NULL
been	NULL
studied	NULL
,	NULL
less	NULL
is	NULL
known	NULL
about	NULL
the	NULL
in	NULL
vivo	NULL
function	NULL
of	NULL
the	NULL
CBF	NULL
B	NULL
subunit	NULL
.	NULL

CBF	NULL
B	NULL
was	NULL
initially	NULL
identified	NULL
as	NULL
a	NULL
protein	NULL
that	NULL
copu-rified	NULL
with	NULL
CBF	NULL
«	NULL
(	NULL
17	NULL
,	NULL
33	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Unrelated	NULL
to	NULL
any	NULL
known	NULL
genes	NULL
,	NULL
CBF	NULL
B	NULL
is	NULL
encoded	NULL
by	NULL
a	NULL
single	NULL
gene	NULL
called	NULL
CBF	NULL
B	NULL
(	NULL
Pebp2	NULL
$	NULL
B	NULL
)	NULL
(	NULL
33	NULL
,	NULL
50	NULL
)	NULL
.	NULL

There	NULL
are	NULL
at	NULL
least	NULL
four	NULL
forms	NULL
of	NULL
CBF	NULL
B	NULL
due	NULL
to	NULL
alternative	NULL
splicing	NULL
(	NULL
33	NULL
,	NULL
50	NULL
)	NULL
.	NULL

None	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
DNA	NULL
.	NULL

However	NULL
,	NULL
some	NULL
forms	NULL
of	NULL
CBF	NULL
B	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
CBF	NULL
a	NULL
in	NULL
vitro	NULL
and	NULL
increase	NULL
its	NULL
affinity	NULL
for	NULL
DNA	NULL
(	NULL
33	NULL
,	NULL
50	NULL
)	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
the	NULL
two	NULL
heterologous	NULL
subunits	NULL
is	NULL
mediated	NULL
through	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
the	NULL
Runt	NULL
domain	NULL
of	NULL
CBF	NULL
«	NULL
(	NULL
16	NULL
,	NULL
25	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
CBF	NULL
B	NULL
gene	NULL
has	NULL
also	NULL
been	NULL
implicated	NULL
in	NULL
AML	NULL
(	NULL
21	NULL
)	NULL
.	NULL

A	NULL
pericentric	NULL
inversion	NULL
of	NULL
chromosome	NULL
16	NULL
[	NULL
inv	NULL
{	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13q22	NULL
)	NULL
]	NULL
that	NULL
is	NULL
characteristically	NULL
observed	NULL
in	NULL
humans	NULL
with	NULL
AML	NULL
of	NULL
the	NULL
M4	NULL
eosinophil	NULL
subtype	NULL
results	NULL
in	NULL
fusion	NULL
of	NULL
CBF	NULL
B	NULL
to	NULL
a	NULL
smooth	NULL
muscle	NULL
myosin	NULL
heavy-chain	NULL
gene	NULL
,	NULL
MYH71	NULL
.	NULL

This	NULL
inversion	NULL
results	NULL
in	NULL
a	NULL
transcript	NULL
encoding	NULL
a	NULL
fusion	NULL
protein	NULL
in	NULL
which	NULL
the	NULL
first	NULL
165	NULL
amino	NULL
acids	NULL
of	NULL
CBF	NULL
B	NULL
are	NULL
linked	NULL
to	NULL
a	NULL
variable	NULL
length	NULL
portion	NULL
of	NULL
the	NULL
carboxyl	NULL
tail	NULL
of	NULL
the	NULL
myosin	NULL
chain	NULL
.	NULL

Both	NULL
the	NULL
CbfaI-	NULL
and	NULL
Chfo2-encoded	NULL
forms	NULL
of	NULL
CBF	NULL
a	NULL
have	NULL
been	NULL
shown	NULL
recently	NULL
to	NULL
have	NULL
transcriptional	NULL
activity	NULL
on	NULL
the	NULL
TCR	NULL
B	NULL
enhancer	NULL
in	NULL
cotransfection	NULL
assays	NULL
(	NULL
2	NULL
,	NULL
34	NULL
)	NULL
.	NULL

We	NULL
wished	NULL
to	NULL
determine	NULL
whether	NULL
it	NULL
is	NULL
also	NULL
active	NULL
on	NULL
the	NULL
enhancer	NULL
core	NULL
sequences	NULL
that	NULL
are	NULL
present	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeats	NULL
(	NULL
LTRs	NULL
)	NULL
of	NULL
the	NULL
murine	NULL
leukemia	NULL
virus	NULL
(	NULL
MuLV	NULL
)	NULL
family	NULL
of	NULL
retroviruses	NULL
.	NULL

MuLV	NULL
enhancer	NULL
cores	NULL
are	NULL
critical	NULL
genetic	NULL
determinants	NULL
of	NULL
viral	NULL
leukemogenicity	NULL
.	NULL

Mutation	NULL
of	NULL
2	NULL
bp	NULL
in	NULL
the	NULL
core	NULL
of	NULL
Moloney	NULL
MuLV	NULL
changed	NULL
the	NULL
leukemogenic	NULL
specificity	NULL
of	NULL
the	NULL
virus	NULL
from	NULL
thymic	NULL
lymphoma	NULL
to	NULL
erythroleukemia	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
3	NULL
bp	NULL
in	NULL
each	NULL
of	NULL
four	NULL
enhancer	NULL
cores	NULL
of	NULL
SL3-3	NULL
(	NULL
SL3	NULL
)	NULL
strongly	NULL
reduced	NULL
the	NULL
capacity	NULL
of	NULL
this	NULL
virus	NULL
to	NULL
induce	NULL
T-cell	NULL
lymphomas	NULL
(	NULL
13	NULL
)	NULL
.	NULL

A	NULL
1-bp	NULL
difference	NULL
between	NULL
the	NULL
enhancer	NULL
cores	NULL
of	NULL
SL3	NULL
and	NULL
a	NULL
highly	NULL
homologous	NULL
,	NULL
nonleukemogenic	NULL
MuLV	NULL
,	NULL
Akv	NULL
,	NULL
also	NULL
significantly	NULL
reduced	NULL
viral	NULL
leukemogenicity	NULL
(	NULL
29	NULL
)	NULL
and	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
SL3	NULL
LTR	NULL
specifically	NULL
in	NULL
T	NULL
lymphocytes	NULL
(	NULL
4	NULL
)	NULL
.	NULL

As	NULL
both	NULL
the	NULL
Cbfal	NULL
and	NULL
Cbfa2	NULL
genes	NULL
are	NULL
expressed	NULL
in	NULL
T	NULL
lymphocytes	NULL
(	NULL
3	NULL
,	NULL
34	NULL
,	NULL
39	NULL
)	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
CBF	NULL
a	NULL
subunit	NULL
encoded	NULL
by	NULL
the	NULL
mouse	NULL
Cbfa2	NULL
gene	NULL
is	NULL
transcriptionally	NULL
active	NULL
on	NULL
the	NULL
MuLV	NULL
enhancer	NULL
cores	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
it	NULL
could	NULL
distinguish	NULL
the	NULL
1-bp	NULL
difference	NULL
between	NULL
the	NULL
SL3	NULL
and	NULL
Akv	NULL
cores	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
the	NULL
activity	NULL
of	NULL
CBF	NULL
B	NULL
in	NULL
transcription	NULL
assays	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
minimal	NULL
essential	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
glutamine	NULL
.	NULL

P19	NULL
is	NULL
a	NULL
mouse	NULL
embryonal	NULL
carcinoma	NULL
cell	NULL
line	NULL
.	NULL

P19	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
medium	NULL
with	NULL
the	NULL
same	NULL
supplements	NULL
.	NULL

Both	NULL
lines	NULL
were	NULL
grown	NULL
at	NULL
37°C	NULL
in	NULL
100	NULL
%	NULL
humidity	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
grown	NULL
under	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
while	NULL
P19	NULL
cells	NULL
were	NULL
grown	NULL
with	NULL
7.5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

L691	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
same	NULL
conditions	NULL
as	NULL
P19	NULL
cells	NULL
.	NULL

Plasmids	NULL
.	NULL

The	NULL
reporter	NULL
plasmids	NULL
SL3	NULL
and	NULL
SAA	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
19	NULL
,	NULL
29	NULL
,	NULL
40	NULL
)	NULL
.	NULL

The	NULL
mutated	NULL
reporter	NULL
plasmids	NULL
Mut	NULL
.	NULL

core	NULL
I	NULL
,	NULL
Mut	NULL
.	NULL

core	NULL
II	NULL
,	NULL
and	NULL
Mut	NULL
.	NULL

core	NULL
I	NULL
&	NULL
II	NULL
were	NULL
constructed	NULL
by	NULL
using	NULL
PCR-based	NULL
mutagenesis	NULL
.	NULL

Primers	NULL
containing	NULL
the	NULL
appropriately	NULL
altered	NULL
bases	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
and	NULL
convenient	NULL
restriction	NULL
sites	NULL
were	NULL
synthesized	NULL
and	NULL
purified	NULL
.	NULL

The	NULL
upstream	NULL
primer	NULL
,	NULL
5°	NULL
AGTATCCTCGAGGCTG	NULL
CAGTAACGCCATTITGCAAGGCAT	NULL
3	NULL
'	NULL
,	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
U3	NULL
region	NULL
of	NULL
SL3	NULL
.	NULL

This	NULL
primer	NULL
contained	NULL
an	NULL
Xhol	NULL
site	NULL
corresponding	NULL
to	NULL
the	NULL
XhoI	NULL
site	NULL
in	NULL
the	NULL
SL3-chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
downstream	NULL
primer	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
SL3	NULL
enhancer	NULL
in	NULL
a	NULL
region	NULL
spanning	NULL
the	NULL
corresponding	NULL
core	NULL
elements	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
primer	NULL
for	NULL
Mut	NULL
.	NULL

core	NULL
I	NULL
was	NULL
5°	NULL
TGGGCCGGGGCCCTAGTGCTTAACGGCAGATATCCTGTCGT	NULL
TAGCGGTCTGGGGACCATC	NULL
3	NULL
'	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
primer	NULL
used	NULL
to	NULL
make	NULL
Mut	NULL
.	NULL

core	NULL
II	NULL
and	NULL
Mut	NULL
.	NULL

core	NULL
I	NULL
&	NULL
II	NULL
was	NULL
5°	NULL
GCTTAACGGCAGATATCCTGTC	NULL
GTTAGCGTGATGGGGACCATCTGTTCTTGGCCCTGGG	NULL
3	NULL
'	NULL
.	NULL

The	NULL
underlined	NULL
bases	NULL
indicate	NULL
the	NULL
mutated	NULL
nucleotides	NULL
relative	NULL
to	NULL
wild-type	NULL
SL3	NULL
.	NULL

The	NULL
downstream	NULL
primer	NULL
for	NULL
Mut	NULL
.	NULL

core	NULL
I	NULL
contained	NULL
an	NULL
Apel	NULL
site	NULL
,	NULL
while	NULL
that	NULL
for	NULL
Mut	NULL
.	NULL

core	NULL
II	NULL
and	NULL
Mut	NULL
.	NULL

core	NULL
I	NULL
&	NULL
II	NULL
had	NULL
an	NULL
EcoRV	NULL
site	NULL
corresponding	NULL
to	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
SL3	NULL
enhancer	NULL
.	NULL

PCR	NULL
was	NULL
then	NULL
performed	NULL
with	NULL
these	NULL
purified	NULL
primers	NULL
on	NULL
a	NULL
wild-type	NULL
SL3	NULL
LTR	NULL
or	NULL
a	NULL
core	NULL
I	NULL
mutant	NULL
LTR	NULL
template	NULL
.	NULL

As	NULL
the	NULL
enhancer	NULL
had	NULL
two	NULL
tandem	NULL
72-bp	NULL
repeats	NULL
,	NULL
conditions	NULL
were	NULL
optimized	NULL
to	NULL
obtain	NULL
a	NULL
high	NULL
percentage	NULL
of	NULL
products	NULL
in	NULL
which	NULL
the	NULL
sites	NULL
were	NULL
mutated	NULL
in	NULL
both	NULL
repeats	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

PCR	NULL
cycling	NULL
conditions	NULL
were	NULL
1	NULL
cycle	NULL
at	NULL
95°C	NULL
for	NULL
2	NULL
min	NULL
followed	NULL
by	NULL
30	NULL
cycles	NULL
at	NULL
95°C	NULL
for	NULL
1	NULL
min	NULL
and	NULL
72°C	NULL
for	NULL
2	NULL
min	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
then	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
and	NULL
cut	NULL
with	NULL
cither	NULL
Xhol-4pel	NULL
or	NULL
Xhol-EcoRV	NULL
.	NULL

Apel	NULL
and	NULL
EcoRV	NULL
cut	NULL
the	NULL
enhancer	NULL
once	NULL
in	NULL
cach	NULL
72-bp	NULL
repeat	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
digestion	NULL
cleaved	NULL
the	NULL
PCR	NULL
product	NULL
into	NULL
two	NULL
major	NULL
fragments	NULL
,	NULL
an	NULL
Xhol-Apel	NULL
162-bp	NULL
piece	NULL
or	NULL
Xhol-EcoRV	NULL
141-bp	NULL
piece	NULL
and	NULL
an	NULL
Apal-Apal	NULL
or	NULL
EcoRV-EcoRV	NULL
72-bp	NULL
piece	NULL
.	NULL

The	NULL
larger	NULL
piece	NULL
was	NULL
inserted	NULL
into	NULL
a	NULL
subclone	NULL
of	NULL
the	NULL
SL3	NULL
LTR	NULL
in	NULL
pSP73	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
creating	NULL
an	NULL
LTR	NULL
with	NULL
a	NULL
single	NULL
72-bp	NULL
unit	NULL
.	NULL

The	NULL
72-bp	NULL
fragment	NULL
was	NULL
then	NULL
inserted	NULL
into	NULL
the	NULL
subclone	NULL
,	NULL
yielding	NULL
tandem	NULL
72-bp	NULL
repeats	NULL
.	NULL

The	NULL
modified	NULL
LTRs	NULL
were	NULL
subsequently	NULL
excised	NULL
and	NULL
inserted	NULL
into	NULL
the	NULL
CAT	NULL
plasmid	NULL
.	NULL

The	NULL
clones	NULL
were	NULL
sequenced	NULL
at	NULL
every	NULL
TRANSCRIPTIONAL	NULL
ACTIVATION	NULL
OF	NULL
CBF	NULL
ON	NULL
THE	NULL
SL3	NULL
LTR	NULL
2899	NULL
A	NULL
Xho	NULL
I	NULL
SL3	NULL
LTR____us	NULL
CAT	NULL
AGACCGCT	NULL
TGTGGTTA	NULL
I	NULL
1k	NULL
saa	NULL
i	NULL
j	NULL
i	NULL
(	NULL
IDC	NULL
Mut	NULL
.	NULL

core	NULL
|	NULL
TQA	NULL
1d	NULL
Mut	NULL
.	NULL

core	NULL
II	NULL
TCA	NULL
fae	NULL
Mut	NULL
.	NULL

core	NULL
|	NULL
&	NULL
It	NULL
B	NULL
RSV	NULL
Enhancer	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
sequences	NULL
within	NULL
plasmids	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
reporter	NULL
plasmid	NULL
used	NULL
in	NULL
cotransfection	NULL
assays	NULL
.	NULL

SL3	NULL
LTR	NULL
se-quences	NULL
,	NULL
shown	NULL
in	NULL
black	NULL
,	NULL
include	NULL
443	NULL
bp	NULL
of	NULL
the	NULL
U3	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
transcriptional	NULL
initiation	NULL
site	NULL
at	NULL
the	NULL
U3/R	NULL
junction	NULL
plus	NULL
32	NULL
bp	NULL
of	NULL
the	NULL
R	NULL
region	NULL
.	NULL

These	NULL
are	NULL
positioned	NULL
upstream	NULL
of	NULL
the	NULL
cet	NULL
gene	NULL
.	NULL

The	NULL
full-size	NULL
arrows	NULL
under	NULL
the	NULL
enhancer	NULL
denote	NULL
the	NULL
tandem	NULL
,	NULL
72-bp	NULL
repeats	NULL
that	NULL
comprise	NULL
the	NULL
enhancer	NULL
.	NULL

The	NULL
small	NULL
arrow	NULL
denotes	NULL
a	NULL
third	NULL
partial	NULL
repeat	NULL
.	NULL

The	NULL
expanded	NULL
view	NULL
of	NULL
part	NULL
of	NULL
one	NULL
repeat	NULL
shows	NULL
the	NULL
sequences	NULL
and	NULL
orientations	NULL
of	NULL
the	NULL
two	NULL
core	NULL
elements	NULL
within	NULL
a	NULL
single	NULL
repeat	NULL
.	NULL

Underneath	NULL
the	NULL
core	NULL
I	NULL
sequence	NULL
is	NULL
the	NULL
single	NULL
nucleotide	NULL
difference	NULL
found	NULL
in	NULL
the	NULL
core	NULL
element	NULL
of	NULL
Akv	NULL
virus	NULL
(	NULL
SAA	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
nucleotides	NULL
that	NULL
were	NULL
changed	NULL
in	NULL
the	NULL
core	NULL
element	NULL
mutations	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
General	NULL
schematic	NULL
diagram	NULL
of	NULL
all	NULL
constructs	NULL
used	NULL
to	NULL
express	NULL
the	NULL
multiple	NULL
subunits	NULL
of	NULL
CBF	NULL
.	NULL

The	NULL
cDNA	NULL
encoding	NULL
a	NULL
particular	NULL
subunit	NULL
was	NULL
placed	NULL
downstream	NULL
of	NULL
the	NULL
RSV	NULL
LTR	NULL
.	NULL

step	NULL
to	NULL
ensure	NULL
that	NULL
they	NULL
were	NULL
identical	NULL
to	NULL
the	NULL
parental	NULL
sequence	NULL
except	NULL
for	NULL
the	NULL
mutated	NULL
bases	NULL
.	NULL

A	NULL
2,047-bp	NULL
fragment	NULL
of	NULL
CBFo2-451	NULL
containing	NULL
the	NULL
entire	NULL
open	NULL
reading	NULL
frame	NULL
was	NULL
subcloned	NULL
between	NULL
the	NULL
HindIII	NULL
and	NULL
Bg/lI	NULL
sites	NULL
of	NULL
plasmid	NULL
pRSV-B-globin	NULL
(	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
,	NULL
replacing	NULL
the	NULL
B-globin	NULL
gene	NULL
.	NULL

CBFa2-451	NULL
was	NULL
expressed	NULL
from	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
(	NULL
RSV	NULL
)	NULL
promoter	NULL
and	NULL
enhancer	NULL
.	NULL

cDNAs	NULL
encoding	NULL
the	NULL
CBF	NULL
(	NULL
subunits	NULL
(	NULL
CBF	NULL
B-187	NULL
,	NULL
CBF	NULL
B-182	NULL
,	NULL
and	NULL
CBF	NULL
B-148	NULL
)	NULL
were	NULL
also	NULL
subcloned	NULL
into	NULL
the	NULL
modified	NULL
RSV	NULL
expression	NULL
vector	NULL
.	NULL

All	NULL
plasmids	NULL
for	NULL
transfections	NULL
of	NULL
mammalian	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
using	NULL
Qiagen	NULL
columns	NULL
.	NULL

Transfections	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

Transient	NULL
transfections	NULL
of	NULL
P19	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
an	NULL
optimized	NULL
Lipofectin	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
protocol	NULL
.	NULL

Cells	NULL
were	NULL
plated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
10	NULL
%	NULL
/60-mm*	NULL
plate	NULL
24	NULL
h	NULL
before	NULL
transfection	NULL
.	NULL

The	NULL
manufacturer	NULL
's	NULL
protocol	NULL
was	NULL
then	NULL
followed	NULL
,	NULL
using	NULL
a	NULL
total	NULL
of	NULL
8	NULL
ug	NULL
of	NULL
DNA	NULL
(	NULL
1.5	NULL
ug	NULL
of	NULL
CAT	NULL
reporter	NULL
,	NULL
1.5	NULL
g	NULL
of	NULL
a	NULL
simian	NULL
virus	NULL
40-luciferase	NULL
internal	NULL
control	NULL
,	NULL
and	NULL
up	NULL
to	NULL
5	NULL
g	NULL
of	NULL
CBF	NULL
subunit	NULL
)	NULL
plus	NULL
25	NULL
pl	NULL
of	NULL
Lipofectin	NULL
per	NULL
transfection	NULL
.	NULL

When	NULL
lower	NULL
amounts	NULL
of	NULL
plasmid	NULL
were	NULL
used	NULL
,	NULL
pBluescript	NULL
DNA	NULL
was	NULL
included	NULL
so	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
in	NULL
every	NULL
culture	NULL
was	NULL
the	NULL
same	NULL
.	NULL

The	NULL
medium	NULL
was	NULL
changed	NULL
after	NULL
a	NULL
6-h	NULL
incubation	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
30	NULL
h	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
4	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Transfections	NULL
of	NULL
L691	NULL
cells	NULL
were	NULL
performed	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
protein	NULL
in	NULL
the	NULL
lysate	NULL
was	NULL
then	NULL
determined	NULL
by	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
kit	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
the	NULL
lysate	NULL
was	NULL
then	NULL
used	NULL
to	NULL
measure	NULL
CAT	NULL
enzymatic	NULL
activity	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
,	NULL
40	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
another	NULL
aliquot	NULL
of	NULL
lysate	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
luciferase	NULL
activity	NULL
from	NULL
the	NULL
internal	NULL
control	NULL
plasmid	NULL
(	NULL
5	NULL
)	NULL
.	NULL

In	NULL
HeLa	NULL
cells	NULL
,	NULL
CAT	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
these	NULL
values	NULL
.	NULL

In	NULL
P19	NULL
cells	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
obtain	NULL
usable	NULL
measurements	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

With	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
enhancer/promoter	NULL
driving	NULL
luciferase	NULL
expression	NULL
,	NULL
activity	NULL
was	NULL
found	NULL
to	NULL
decrease	NULL
about	NULL
10-fold	NULL
at	NULL
the	NULL
highest	NULL
concentration	NULL
of	NULL
CBFa2-451	NULL
expression	NULL
plasmid	NULL
used	NULL
.	NULL

Two	NULL
other	NULL
luciferase	NULL
constructs	NULL
,	NULL
one	NULL
with	NULL
the	NULL
mouse	NULL
mammary	NULL
tumor	NULL
virus	NULL
LTR	NULL
with	NULL
the	NULL
negative	NULL
regulatory	NULL
clement	NULL
in	NULL
U3	NULL
deleted	NULL
and	NULL
the	NULL
other	NULL
with	NULL
a	NULL
sea	NULL
urchin	NULL
embryonic	NULL
histone	NULL
gene	NULL
promoter	NULL
,	NULL
resulted	NULL
in	NULL
no	NULL
detectable	NULL
activity	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
avoid	NULL
overestimating	NULL
the	NULL
stimulation	NULL
by	NULL
CBFo2-451	NULL
,	NULL
the	NULL
luciferase	NULL
internal	NULL
control	NULL
was	NULL
not	NULL
used	NULL
in	NULL
comparing	NULL
different	NULL
transfections	NULL
in	NULL
P19	NULL
cells	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
determined	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
of	NULL
thin-layer	NULL
chromatography	NULL
plates	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
chloramphenicol	NULL
acetylated	NULL
was	NULL
calculated	NULL
.	NULL

The	NULL
level	NULL
of	NULL
transactivation	NULL
by	NULL
CBF	NULL
was	NULL
then	NULL
calculated	NULL
by	NULL
dividing	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
LTR-CAT	NULL
plasmid	NULL
(	NULL
normalized	NULL
to	NULL
luciferase	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CBF	NULL
by	NULL
the	NULL
level	NULL
of	NULL
activity	NULL
in	NULL
a	NULL
parallel	NULL
sample	NULL
without	NULL
CBF	NULL
.	NULL

Multiple	NULL
trials	NULL
were	NULL
performed	NULL
for	NULL
cach	NULL
2900	NULL
ZAIMAN	NULL
ET	NULL
AL	NULL
.	NULL

experiment	NULL
.	NULL

The	NULL
means	NULL
were	NULL
calculated	NULL
and	NULL
plotted	NULL
.	NULL

Standard	NULL
deviations	NULL
were	NULL
calculated	NULL
and	NULL
plotted	NULL
for	NULL
each	NULL
mean	NULL
,	NULL
using	NULL
the	NULL
STDEVP	NULL
program	NULL
of	NULL
Microsoft	NULL
Excel	NULL
.	NULL

Expression	NULL
and	NULL
partial	NULL
purification	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
CBFa2-451	NULL
.	NULL

A	NULL
DNA	NULL
fragment	NULL
encoding	NULL
a	NULL
17-kDa	NULL
DNA	NULL
binding	NULL
(	NULL
Runt	NULL
)	NULL
domain	NULL
from	NULL
the	NULL
mouse	NULL
CBFa2-451	NULL
protein	NULL
(	NULL
amino	NULL
acids	NULL
51	NULL
to	NULL
202	NULL
)	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
using	NULL
a	NULL
5	NULL
'	NULL
(	NULL
sense	NULL
)	NULL
primer	NULL
(	NULL
CGGAATTCCCATATGGTGGAGGTACTAGCT	NULL
)	NULL
and	NULL
a	NULL
3	NULL
'	NULL
(	NULL
antisense	NULL
)	NULL
primer	NULL
(	NULL
CGGATCCTTACTCCAATTCACTGAGCCG	NULL
)	NULL
.	NULL

The	NULL
amplified	NULL
fragment	NULL
was	NULL
digested	NULL
with	NULL
Nde	NULL
!	NULL

and	NULL
BemHI	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
Ndel-BamHI	NULL
sites	NULL
of	NULL
a	NULL
modified	NULL
pET3	NULL
vector	NULL
lacking	NULL
the	NULL
codons	NULL
of	NULL
T7	NULL
gene	NULL
10	NULL
(	NULL
32	NULL
)	NULL
.	NULL

This	NULL
synthetic	NULL
DNA	NULL
contains	NULL
a	NULL
methionine	NULL
codon	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
Nadel	NULL
site	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
first	NULL
amino	NULL
acid	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

For	NULL
expression	NULL
and	NULL
purification	NULL
,	NULL
the	NULL
plasmid	NULL
was	NULL
transformed	NULL
into	NULL
Escherichia	NULL
coli	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
containing	NULL
plasmid	NULL
pLysS	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Expression	NULL
was	NULL
induced	NULL
with	NULL
1	NULL
mM	NULL
isopropylthiogalactopyranoside	NULL
(	NULL
IPTG	NULL
)	NULL
for	NULL
3	NULL
h	NULL
at	NULL
37°C	NULL
(	NULL
Ag	NULL
,	NULL
,	NULL
=	NULL
0.7	NULL
to	NULL
0.9	NULL
at	NULL
time	NULL
of	NULL
induction	NULL
and	NULL
1	NULL
to	NULL
1.5	NULL
at	NULL
time	NULL
of	NULL
harvest	NULL
)	NULL
.	NULL

The	NULL
bacterial	NULL
cell	NULL
pellet	NULL
from	NULL
a	NULL
1-liter	NULL
culture	NULL
was	NULL
resuspended	NULL
in	NULL
equal-weight	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
%	NULL
sucrose	NULL
,	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
)	NULL
,	NULL
protease	NULL
inhibitors	NULL
[	NULL
1	NULL
mM	NULL
Pefabloc	NULL
,	NULL
1	NULL
mM	NULL
phenyl-methylsulfonyl	NULL
fluoride	NULL
,	NULL
50	NULL
p.M	NULL
calpain	NULL
inhibitor	NULL
1	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
1	NULL
pg	NULL
of	NULL
pepstatin	NULL
A	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
aprotinin	NULL
per	NULL
mil	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
frozen	NULL
by	NULL
being	NULL
dropped	NULL
directly	NULL
into	NULL
liquid	NULL
nitrogen	NULL
,	NULL
thawed	NULL
in	NULL
a	NULL
room	NULL
temperature	NULL
water	NULL
bath	NULL
,	NULL
incubated	NULL
on	NULL
ice	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
400	NULL
mg	NULL
of	NULL
lysozyme	NULL
per	NULL
ml	NULL
and	NULL
0.1	NULL
M	NULL
ammonium	NULL
sulfate	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
then	NULL
lysed	NULL
with	NULL
gentle	NULL
agitation	NULL
for	NULL
3	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Samples	NULL
were	NULL
centrifuged	NULL
at	NULL
40,000	NULL
x	NULL
g	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Soluble	NULL
proteins	NULL
were	NULL
dialyzed	NULL
against	NULL
200	NULL
volumes	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
150	NULL
mM	NULL
KCI	NULL
,	NULL
20	NULL
mM	NULL
imidazole	NULL
[	NULL
pH	NULL
7.0	NULL
]	NULL
,	NULL
20	NULL
mM	NULL
B-mercaptocthanol	NULL
)	NULL
.	NULL

After	NULL
dialysis	NULL
,	NULL
samples	NULL
were	NULL
applied	NULL
to	NULL
a	NULL
DEAE-Sephacel	NULL
column	NULL
(	NULL
24	NULL
ml	NULL
)	NULL
equilibrated	NULL
in	NULL
buffer	NULL
A	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
1.5	NULL
column	NULL
volumes	NULL
buffer	NULL
A	NULL
,	NULL
and	NULL
approximately	NULL
2-ml	NULL
fractions	NULL
were	NULL
collected	NULL
.	NULL

Flowthrough	NULL
fractions	NULL
containing	NULL
core	NULL
binding	NULL
activity	NULL
were	NULL
pooled	NULL
and	NULL
dialyzed	NULL
against	NULL
200	NULL
volumes	NULL
buffer	NULL
B	NULL
(	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
N-2-hydroxy-ethylpiperazine-N	NULL
'	NULL
-2-cthanesulfonic	NULL
acid	NULL
[	NULL
MEPES	NULL
;	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
20	NULL
mM	NULL
B-mercapto-ethanol	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.05	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
and	NULL
then	NULL
applied	NULL
to	NULL
a	NULL
P-11	NULL
cellulose	NULL
phosphate	NULL
column	NULL
(	NULL
3	NULL
ml	NULL
;	NULL
Whatman	NULL
)	NULL
equilibrated	NULL
in	NULL
buffer	NULL
B	NULL
.	NULL

Core	NULL
binding	NULL
activity	NULL
was	NULL
eluted	NULL
with	NULL
a	NULL
30-ml	NULL
linear	NULL
gradient	NULL
of	NULL
NaCl	NULL
from	NULL
50	NULL
mM	NULL
to	NULL
1.0	NULL
M	NULL
in	NULL
buffer	NULL
B	NULL
.	NULL

Approximately	NULL
1-ml	NULL
fractions	NULL
were	NULL
collected	NULL
.	NULL

Fractions	NULL
with	NULL
peak	NULL
activity	NULL
were	NULL
pooled	NULL
,	NULL
exchanged	NULL
into	NULL
buffer	NULL
C	NULL
[	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
2-	NULL
(	NULL
N-mor-pholino	NULL
)	NULL
ethanesulfonic	NULL
acid	NULL
(	NULL
pH	NULL
6.5	NULL
)	NULL
,	NULL
20	NULL
mM	NULL
B-mercaptocthanol	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.05	NULL
%	NULL
Triton	NULL
X-100	NULL
]	NULL
on	NULL
a	NULL
Sephadex	NULL
G-25	NULL
column	NULL
,	NULL
and	NULL
then	NULL
applied	NULL
to	NULL
a	NULL
Mono	NULL
S	NULL
column	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Bound	NULL
protein	NULL
was	NULL
eluted	NULL
with	NULL
a	NULL
60-ml	NULL
linear	NULL
gradient	NULL
from	NULL
50	NULL
mM	NULL
to	NULL
1.0	NULL
M	NULL
NaCl	NULL
Active	NULL
fractions	NULL
were	NULL
pooled	NULL
,	NULL
and	NULL
glycerol	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
20	NULL
%	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
domain	NULL
51-202	NULL
was	NULL
estimated	NULL
to	NULL
be	NULL
20	NULL
to	NULL
30	NULL
%	NULL
pure	NULL
by	NULL
Coomassie	NULL
brilliant	NULL
blue	NULL
staining	NULL
of	NULL
a	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
.	NULL

Protein-DNA	NULL
binding	NULL
analysis	NULL
.	NULL

Complementary	NULL
18-bp	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
SL3	NULL
and	NULL
Akv	NULL
core	NULL
site	NULL
(	NULL
4	NULL
)	NULL
,	NULL
the	NULL
high-affinity	NULL
core	NULL
site	NULL
deduced	NULL
by	NULL
Thornell	NULL
et	NULL
al	NULL
.	NULL

(	NULL
47	NULL
)	NULL
and	NULL
Wang	NULL
and	NULL
Speck	NULL
(	NULL
49	NULL
)	NULL
,	NULL
and	NULL
a	NULL
mutant	NULL
core	NULL
site	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4C	NULL
for	NULL
sequences	NULL
)	NULL
were	NULL
synthesized	NULL
on	NULL
a	NULL
Biosearch	NULL
Cyclone	NULL
DNA	NULL
synthesizer	NULL
at	NULL
Dartmouth	NULL
Medical	NULL
School	NULL
and	NULL
purified	NULL
by	NULL
electrophoresis	NULL
through	NULL
20	NULL
%	NULL
poly-acrylamide-7	NULL
M	NULL
urea	NULL
gels	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

*°P-labeled	NULL
DNA	NULL
probes	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Binding	NULL
reaction	NULL
mixtures	NULL
contained	NULL
20,000	NULL
cpm	NULL
of	NULL
*°P-end-labeled	NULL
high-affinity-site	NULL
probe	NULL
,	NULL
0.5	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
»	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
0.5	NULL
ul	NULL
of	NULL
protein	NULL
sample	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
the	NULL
SL3	NULL
,	NULL
Akv	NULL
,	NULL
or	NULL
high-affinity	NULL
mutant	NULL
core	NULL
site	NULL
com-petitor	NULL
.	NULL

The	NULL
data	NULL
were	NULL
scanned	NULL
and	NULL
analyzed	NULL
with	NULL
the	NULL
NIH	NULL
Image	NULL
program	NULL
.	NULL

RESULTS	NULL
Transcriptional	NULL
activity	NULL
of	NULL
CBF	NULL
&	NULL
on	NULL
an	NULL
MuLV	NULL
enhancer	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
CBF	NULL
a	NULL
subunit	NULL
encoded	NULL
by	NULL
the	NULL
murine	NULL
Cbfa2	NULL
gene	NULL
to	NULL
transactivate	NULL
the	NULL
LTR	NULL
of	NULL
the	NULL
T-cell	NULL
lymphomagenic	NULL
MuLV	NULL
,	NULL
SL3	NULL
.	NULL

The	NULL
CBFa2-451	NULL
cDNA	NULL
encodes	NULL
a	NULL
451-amino-acid	NULL
polypeptide	NULL
identical	NULL
to	NULL
PEBP2	NULL
«	NULL
B1	NULL
(	NULL
2	NULL
,	NULL
3	NULL
,	NULL
7	NULL
)	NULL
.	NULL

A	NULL
schematic	NULL
representation	NULL
of	NULL
this	NULL
cDNA	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
CBFa2-451	NULL
cDNA	NULL
was	NULL
cloned	NULL
into	NULL
an	NULL
expression	NULL
vector	NULL
downstream	NULL
of	NULL
the	NULL
RSV	NULL
LTR	NULL
and	NULL
cotransfected	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
SL3	NULL
LTR	NULL
upstream	NULL
of	NULL
the	NULL
bacterial	NULL
reporter	NULL
gene	NULL
cat	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
SL3	NULL
LTR	NULL
enhancer	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
72-bp	NULL
repeats	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
there	NULL
are	NULL
two	NULL
different	NULL
core	NULL
elements	NULL
to	NULL
which	NULL
CBF	NULL
binds	NULL
in	NULL
each	NULL
repeat	NULL
,	NULL
making	NULL
a	NULL
total	NULL
of	NULL
four	NULL
CBF	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
SL3	NULL
enhancer	NULL
.	NULL

The	NULL
two	NULL
cores	NULL
within	NULL
each	NULL
repeat	NULL
are	NULL
not	NULL
identical	NULL
and	NULL
are	NULL
in	NULL
inverse	NULL
orientation	NULL
relative	NULL
to	NULL
each	NULL
other	NULL
,	NULL
separated	NULL
by	NULL
14	NULL
bp	NULL
.	NULL

Thornell	NULL
et	NULL
al	NULL
.	NULL

(	NULL
47	NULL
)	NULL
termed	NULL
these	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
and	NULL
estimated	NULL
that	NULL
CBF	NULL
from	NULL
mouse	NULL
T	NULL
cells	NULL
bound	NULL
about	NULL
five	NULL
times	NULL
more	NULL
strongly	NULL
to	NULL
core	NULL
I	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
CBFa2-451	NULL
was	NULL
tested	NULL
in	NULL
two	NULL
cell	NULL
lines	NULL
,	NULL
HeLa	NULL
J.	NULL
Virou	NULL
.	NULL

Runt	NULL
Domain	NULL
1	NULL
50	NULL
178	NULL
242	NULL
451	NULL
CBFaz451	NULL
_	NULL
|-	NULL
-|-	NULL
]	NULL
83	NULL
iG	NULL
51	NULL
202	NULL
CBro2	NULL
(	NULL
51-202	NULL
)	NULL
Ream	NULL
|	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
CBFa2-451	NULL
.	NULL

18	NULL
and	NULL
13	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
fusion	NULL
of	NULL
sequences	NULL
from	NULL
chromosomes	NULL
8	NULL
and	NULL
3	NULL
in	NULL
the	NULL
translocated	NULL
forms	NULL
.	NULL

Numbers	NULL
at	NULL
the	NULL
top	NULL
refer	NULL
to	NULL
amino	NULL
acid	NULL
positions	NULL
.	NULL

The	NULL
black	NULL
box	NULL
represents	NULL
the	NULL
Runt	NULL
domain	NULL
.	NULL

CBFo2	NULL
(	NULL
51-202	NULL
)	NULL
is	NULL
the	NULL
portion	NULL
of	NULL
CBFa2-451	NULL
used	NULL
in	NULL
the	NULL
binding	NULL
studies	NULL
.	NULL

and	NULL
P19	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

P19	NULL
cells	NULL
were	NULL
chosen	NULL
because	NULL
the	NULL
Cbfo2	NULL
gene	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
these	NULL
cells	NULL
and	NULL
both	NULL
CbfaI	NULL
and	NULL
Cbfa2	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
transactivate	NULL
the	NULL
TCR	NULL
B	NULL
enhancer	NULL
when	NULL
expressed	NULL
exogenously	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
(	NULL
2	NULL
)	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
chosen	NULL
empirically	NULL
as	NULL
another	NULL
type	NULL
of	NULL
cells	NULL
which	NULL
also	NULL
supported	NULL
CBF	NULL
activity	NULL
.	NULL

In	NULL
both	NULL
lines	NULL
,	NULL
CBFa2-451	NULL
stimulated	NULL
transcription	NULL
from	NULL
the	NULL
SL3	NULL
LTR	NULL
.	NULL

Maximum	NULL
stimulation	NULL
was	NULL
about	NULL
eightfold	NULL
in	NULL
HeLa	NULL
cells	NULL
and	NULL
sixfold	NULL
in	NULL
P19	NULL
cells	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
empty	NULL
RSV	NULL
vector	NULL
was	NULL
tested	NULL
.	NULL

The	NULL
RSV	NULL
vector	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
level	NULL
of	NULL
LTR	NULL
activity	NULL
in	NULL
either	NULL
cell	NULL
line	NULL
.	NULL

In	NULL
P19	NULL
cells	NULL
,	NULL
maximum	NULL
stimulation	NULL
was	NULL
seen	NULL
with	NULL
about	NULL
0.5	NULL
ug	NULL
of	NULL
CBFa2-451	NULL
.	NULL

Higher	NULL
levels	NULL
resulted	NULL
in	NULL
decreased	NULL
levels	NULL
of	NULL
trans-activation	NULL
.	NULL

Perhaps	NULL
excess	NULL
CBFa2-451	NULL
squelched	NULL
transcription	NULL
(	NULL
2	NULL
,	NULL
36	NULL
)	NULL
.	NULL

It	NULL
is	NULL
unclear	NULL
whether	NULL
saturating	NULL
levels	NULL
of	NULL
CBF	NULL
a	NULL
were	NULL
attained	NULL
in	NULL
the	NULL
experiments	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Activity	NULL
of	NULL
CBFa2-451	NULL
on	NULL
different	NULL
core	NULL
sequences	NULL
.	NULL

Core	NULL
I	NULL
in	NULL
SL3	NULL
is	NULL
conserved	NULL
in	NULL
other	NULL
MuLVs	NULL
and	NULL
related	NULL
type	NULL
C	NULL
retrovi-ruses	NULL
,	NULL
while	NULL
core	NULL
II	NULL
is	NULL
not	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
core	NULL
elements	NULL
in	NULL
different	NULL
viruses	NULL
often	NULL
vary	NULL
slightly	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
core	NULL
of	NULL
nonleukemogenic	NULL
Akyv	NULL
virus	NULL
differs	NULL
from	NULL
core	NULL
I	NULL
of	NULL
SL3	NULL
by	NULL
1	NULL
bp	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
(	NULL
19	NULL
)	NULL
.	NULL

This	NULL
T-C	NULL
difference	NULL
has	NULL
a	NULL
large	NULL
effect	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
SL3	NULL
to	NULL
induce	NULL
T-cell	NULL
lymphomas	NULL
(	NULL
29	NULL
)	NULL
.	NULL

It	NULL
also	NULL
affects	NULL
transcription	NULL
in	NULL
T	NULL
lymphocytes	NULL
but	NULL
not	NULL
other	NULL
types	NULL
of	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
29	NULL
)	NULL
.	NULL

CBF	NULL
from	NULL
mouse	NULL
thymocytes	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
bind	NULL
both	NULL
the	NULL
SL3	NULL
and	NULL
Akyv	NULL
cores	NULL
(	NULL
4	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Competition	NULL
binding	NULL
experiments	NULL
by	NULL
Thornell	NULL
et	NULL
al	NULL
.	NULL

(	NULL
47	NULL
)	NULL
indicated	NULL
that	NULL
CBF	NULL
bound	NULL
preferentially	NULL
to	NULL
the	NULL
SL3	NULL
core	NULL
,	NULL
although	NULL
quantitation	NULL
of	NULL
the	NULL
difference	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
.	NULL

Selected	NULL
and	NULL
amplified	NULL
binding	NULL
sequence	NULL
footprint	NULL
analysis	NULL
showed	NULL
that	NULL
calf	NULL
thymus	NULL
CBF	NULL
preferred	NULL
a	NULL
T	NULL
over	NULL
a	NULL
C	NULL
at	NULL
the	NULL
corresponding	NULL
position	NULL
,	NULL
but	NULL
it	NULL
preferred	NULL
C	NULL
to	NULL
other	NULL
bases	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Like	NULL
the	NULL
Akyv	NULL
core	NULL
,	NULL
core	NULL
II	NULL
of	NULL
SL3	NULL
has	NULL
a	NULL
C	NULL
at	NULL
the	NULL
equivalent	NULL
position	NULL
as	NULL
the	NULL
T-C	NULL
difference	NULL
between	NULL
SL3	NULL
and	NULL
Akv	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

To	NULL
quantify	NULL
the	NULL
relative	NULL
binding	NULL
of	NULL
CBF	NULL
«	NULL
to	NULL
the	NULL
SL3	NULL
and	NULL
Akv	NULL
cores	NULL
,	NULL
a	NULL
17-kDa	NULL
portion	NULL
of	NULL
CBFa2-451	NULL
from	NULL
amino	NULL
acids	NULL
51	NULL
through	NULL
202	NULL
[	NULL
CBFa	NULL
«	NULL
2	NULL
(	NULL
51-202	NULL
)	NULL
;	NULL
Fig	NULL
.	NULL

2	NULL
]	NULL
containing	NULL
the	NULL
DNA	NULL
binding	NULL
(	NULL
Runt	NULL
)	NULL
domain	NULL
was	NULL
PCR	NULL
amplified	NULL
and	NULL
expressed	NULL
in	NULL
E.	NULL
coli	NULL
by	NULL
using	NULL
a	NULL
modified	NULL
pET	NULL
3	NULL
vector	NULL
system	NULL
.	NULL

The	NULL
protein	NULL
was	NULL
chromatographically	NULL
enriched	NULL
to	NULL
about	NULL
20	NULL
to	NULL
30	NULL
%	NULL
purity	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
high-affinity	NULL
binding	NULL
site	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
high-affinity	NULL
site	NULL
,	NULL
the	NULL
SL3	NULL
core	NULL
,	NULL
the	NULL
Akyv	NULL
core	NULL
,	NULL
and	NULL
a	NULL
mutated	NULL
core	NULL
element	NULL
as	NULL
competitors	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
SL3	NULL
core	NULL
element	NULL
competed	NULL
for	NULL
binding	NULL
about	NULL
twice	NULL
as	NULL
well	NULL
as	NULL
the	NULL
Akyv	NULL
core	NULL
,	NULL
in	NULL
that	NULL
approximately	NULL
twice	NULL
as	NULL
much	NULL
Akyv	NULL
competitor	NULL
was	NULL
needed	NULL
to	NULL
decrease	NULL
binding	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
the	NULL
SL3	NULL
core	NULL
site	NULL
.	NULL

The	NULL
high-affinity	NULL
site	NULL
competed	NULL
for	NULL
binding	NULL
about	NULL
four	NULL
times	NULL
more	NULL
effectively	NULL
than	NULL
the	NULL
SL3	NULL
core	NULL
.	NULL

The	NULL
mutated	NULL
element	NULL
that	NULL
contained	NULL
a	NULL
crucial	NULL
C-for-G	NULL
substitution	NULL
in	NULL
the	NULL
two	NULL
adjacent	NULL
G	NULL
nucleotides	NULL
present	NULL
in	NULL
the	NULL
functional	NULL
CBF	NULL
binding	NULL
sites	NULL
failed	NULL
to	NULL
compete	NULL
.	NULL

Thus	NULL
,	NULL
CBF	NULL
can	NULL
bind	NULL
to	NULL
core	NULL
sequences	NULL
that	NULL
contain	NULL
a	NULL
T	NULL
or	NULL
C	NULL
at	NULL
the	NULL
position	NULL
that	NULL
distinguishes	NULL
SL3	NULL
from	NULL
Akyv	NULL
,	NULL
but	NULL
there	NULL
is	NULL
a	NULL
preference	NULL
for	NULL
a	NULL
T.	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
A	NULL
6	NULL
P19	NULL
5	NULL
-	NULL
SL3-CAT	NULL
60	NULL
A4	NULL
E	NULL
G	NULL
|	NULL
«	NULL
2-451	NULL
3	NULL
1	NULL
w	NULL
80s	NULL
-	NULL
|	NULL
i-	NULL
L	NULL
1s	NULL
SAA-CAT	NULL
ci	NULL
-	NULL
«	NULL
2-451	NULL
9	NULL
d	NULL
1	NULL
SL3-CAT	NULL
Vector	NULL
Alone	NULL
O	NULL
TT	NULL
f	NULL
Ot	NULL
|f	NULL
1	NULL
7	NULL
ug	NULL
transactivator	NULL
TRANSCRIPTIONAL	NULL
ACTIVATION	NULL
OF	NULL
CBF	NULL
ON	NULL
THE	NULL
SL3	NULL
LTR	NULL
B	NULL
Fold	NULL
Transactivation	NULL
2901	NULL
9	NULL
HeLa	NULL
«	NULL
2-451	NULL
«	NULL
2-451	NULL
SL3-CAT	NULL
ug	NULL
Transactivator	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Titration	NULL
of	NULL
CBFa2-451	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
CBFa2-451	NULL
were	NULL
cotransfected	NULL
with	NULL
1.5	NULL
pg	NULL
of	NULL
the	NULL
indicated	NULL
reporter	NULL
plasmid	NULL
,	NULL
and	NULL
the	NULL
fold	NULL
transactivation	NULL
was	NULL
plotted	NULL
.	NULL

Datum	NULL
points	NULL
are	NULL
the	NULL
means	NULL
of	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
trials	NULL
for	NULL
each	NULL
experiment	NULL
,	NULL
and	NULL
error	NULL
bars	NULL
show	NULL
the	NULL
standard	NULL
deviations	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
was	NULL
kept	NULL
constant	NULL
at	NULL
8	NULL
pg	NULL
in	NULL
all	NULL
experiments	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
pBluescript	NULL
DNA	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
in	NULL
P19	NULL
(	NULL
A	NULL
)	NULL
cells	NULL
and	NULL
HeLa	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
CBFa2-451	NULL
to	NULL
distinguish	NULL
the	NULL
SL3	NULL
and	NULL
Akv	NULL
cores	NULL
was	NULL
then	NULL
tested	NULL
in	NULL
transcription	NULL
assays	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
CBFa2-451	NULL
was	NULL
tested	NULL
by	NULL
using	NULL
a	NULL
recombinant	NULL
enhancer	NULL
(	NULL
termed	NULL
SAA	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
that	NULL
was	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
SL3	NULL
except	NULL
for	NULL
the	NULL
single	NULL
base	NULL
pair	NULL
found	NULL
in	NULL
the	NULL
core	NULL
of	NULL
Akv	NULL
.	NULL

This	NULL
mutation	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
LTR	NULL
reporter	NULL
plasmid	NULL
in	NULL
either	NULL
P19	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
CBFa2-451	NULL
resulted	NULL
in	NULL
equivalent	NULL
levels	NULL
of	NULL
stimulation	NULL
of	NULL
the	NULL
viral	NULL
LTR	NULL
whether	NULL
the	NULL
core	NULL
was	NULL
that	NULL
of	NULL
SL3	NULL
or	NULL
Akyv	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
simplest	NULL
interpretation	NULL
of	NULL
this	NULL
observation	NULL
is	NULL
that	NULL
this	NULL
form	NULL
of	NULL
CBF	NULL
a	NULL
is	NULL
not	NULL
solely	NULL
responsible	NULL
for	NULL
the	NULL
capacity	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
distinguish	NULL
the	NULL
SL3	NULL
and	NULL
Akv	NULL
cores	NULL
.	NULL

One	NULL
possible	NULL
explanation	NULL
for	NULL
the	NULL
equivalent	NULL
activation	NULL
of	NULL
the	NULL
SL3	NULL
and	NULL
Akv	NULL
cores	NULL
by	NULL
CBF	NULL
was	NULL
that	NULL
the	NULL
transient	NULL
expression	NULL
assays	NULL
may	NULL
have	NULL
resulted	NULL
in	NULL
overexpression	NULL
of	NULL
the	NULL
factor	NULL
.	NULL

It	NULL
was	NULL
conceivable	NULL
that	NULL
at	NULL
low	NULL
,	NULL
limiting	NULL
levels	NULL
of	NULL
CBF	NULL
,	NULL
the	NULL
difference	NULL
in	NULL
activity	NULL
between	NULL
the	NULL
two	NULL
cores	NULL
might	NULL
be	NULL
greater	NULL
.	NULL

We	NULL
tested	NULL
this	NULL
possibility	NULL
by	NULL
transfecting	NULL
increasing	NULL
amounts	NULL
of	NULL
CBFa2-451	NULL
into	NULL
L691	NULL
T	NULL
lymphocytes	NULL
,	NULL
a	NULL
cell	NULL
line	NULL
in	NULL
which	NULL
the	NULL
SL3	NULL
LTR	NULL
is	NULL
about	NULL
fivefold	NULL
more	NULL
active	NULL
than	NULL
the	NULL
SAA	NULL
LTR	NULL
.	NULL

Cotransfection	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
CBFa	NULL
«	NULL
2-451	NULL
failed	NULL
to	NULL
alter	NULL
the	NULL
activity	NULL
of	NULL
either	NULL
LTR	NULL
in	NULL
transient	NULL
transfections	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
indicated	NULL
that	NULL
the	NULL
level	NULL
of	NULL
this	NULL
subunit	NULL
of	NULL
CBF	NULL
was	NULL
not	NULL
limiting	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
these	NULL
MuLV	NULL
LTRs	NULL
in	NULL
this	NULL
T-cell	NULL
line	NULL
.	NULL

It	NULL
was	NULL
also	NULL
consistent	NULL
with	NULL
the	NULL
idea	NULL
that	NULL
the	NULL
equivalent	NULL
activities	NULL
of	NULL
the	NULL
SL3	NULL
and	NULL
Akv	NULL
cores	NULL
in	NULL
cotransfection	NULL
assays	NULL
were	NULL
not	NULL
due	NULL
to	NULL
overexpression	NULL
of	NULL
CBF	NULL
that	NULL
resulted	NULL
in	NULL
driving	NULL
the	NULL
SAA	NULL
LTR	NULL
activity	NULL
to	NULL
that	NULL
of	NULL
the	NULL
SL3	NULL
LTR	NULL
.	NULL

It	NULL
was	NULL
important	NULL
to	NULL
confirm	NULL
that	NULL
CBF	NULL
a	NULL
was	NULL
acting	NULL
through	NULL
the	NULL
core	NULL
elements	NULL
in	NULL
the	NULL
SL3	NULL
enhancer	NULL
.	NULL

Mutations	NULL
were	NULL
introduced	NULL
into	NULL
both	NULL
copies	NULL
of	NULL
core	NULL
I	NULL
,	NULL
both	NULL
copies	NULL
of	NULL
core	NULL
II	NULL
,	NULL
or	NULL
all	NULL
four	NULL
CBF	NULL
binding	NULL
sites	NULL
simultaneously	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
2-bp	NULL
mutation	NULL
in	NULL
core	NULL
I	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
block	NULL
CBF	NULL
binding	NULL
(	NULL
49	NULL
)	NULL
,	NULL
as	NULL
was	NULL
the	NULL
3-bp	NULL
mutation	NULL
in	NULL
core	NULL
II	NULL
(	NULL
47	NULL
)	NULL
.	NULL

These	NULL
mutations	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
LTR	NULL
reporter	NULL
plasmids	NULL
in	NULL
either	NULL
P19	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
53	NULL
)	NULL
.	NULL

LTRs	NULL
with	NULL
these	NULL
mutations	NULL
were	NULL
tested	NULL
in	NULL
cotransfection	NULL
experiments	NULL
with	NULL
CBFa2-451	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
P19	NULL
cells	NULL
,	NULL
mutation	NULL
of	NULL
core	NULL
I	NULL
eliminated	NULL
all	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
CBFa2-451	NULL
.	NULL

This	NULL
result	NULL
confirmed	NULL
that	NULL
the	NULL
factor	NULL
acts	NULL
through	NULL
this	NULL
site	NULL
.	NULL

Mutation	NULL
of	NULL
core	NULL
II	NULL
also	NULL
reduced	NULL
the	NULL
level	NULL
of	NULL
transactivation	NULL
by	NULL
CBFa2-451	NULL
,	NULL
but	NULL
the	NULL
effect	NULL
was	NULL
less	NULL
than	NULL
that	NULL
seen	NULL
with	NULL
core	NULL
I	NULL
.	NULL

The	NULL
smaller	NULL
contribution	NULL
of	NULL
core	NULL
II	NULL
to	NULL
the	NULL
total	NULL
effect	NULL
of	NULL
the	NULL
SL3	NULL
enhancer	NULL
was	NULL
consistent	NULL
with	NULL
lower	NULL
binding	NULL
affinity	NULL
for	NULL
CBF	NULL
reported	NULL
by	NULL
Thornell	NULL
et	NULL
al	NULL
.	NULL

(	NULL
47	NULL
)	NULL
and	NULL
is	NULL
analogous	NULL
to	NULL
the	NULL
relative	NULL
effects	NULL
of	NULL
mutation	NULL
of	NULL
each	NULL
of	NULL
the	NULL
cores	NULL
on	NULL
leukemogenicity	NULL
of	NULL
SL3	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Simultaneous	NULL
mutation	NULL
of	NULL
the	NULL
core	NULL
I	NULL
and	NULL
core	NULL
II	NULL
sites	NULL
resulted	NULL
in	NULL
lack	NULL
of	NULL
transactivation	NULL
in	NULL
P19	NULL
cells	NULL
.	NULL

In	NULL
HeLa	NULL
cells	NULL
,	NULL
mutation	NULL
of	NULL
either	NULL
core	NULL
I	NULL
or	NULL
core	NULL
II	NULL
reduced	NULL
the	NULL
level	NULL
of	NULL
transactivation	NULL
to	NULL
about	NULL
threefold	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Simultaneous	NULL
mutation	NULL
of	NULL
all	NULL
four	NULL
sites	NULL
reduced	NULL
the	NULL
level	NULL
of	NULL
transactivation	NULL
to	NULL
about	NULL
twofold	NULL
.	NULL

Thus	NULL
,	NULL
most	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
CBFa2-451	NULL
in	NULL
HeLa	NULL
cells	NULL
is	NULL
indeed	NULL
through	NULL
the	NULL
core	NULL
elements	NULL
.	NULL

However	NULL
,	NULL
there	NULL
was	NULL
a	NULL
residual	NULL
level	NULL
of	NULL
stimulation	NULL
that	NULL
was	NULL
independent	NULL
of	NULL
the	NULL
cores	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
basis	NULL
of	NULL
this	NULL
,	NULL
we	NULL
also	NULL
tested	NULL
a	NULL
mutated	NULL
SL3	NULL
LTR	NULL
in	NULL
which	NULL
the	NULL
5	NULL
'	NULL
300	NULL
bp	NULL
including	NULL
essentially	NULL
the	NULL
entire	NULL
enhancer	NULL
repeat	NULL
region	NULL
was	NULL
deleted	NULL
(	NULL
22	NULL
)	NULL
.	NULL

CBFa2-451	NULL
also	NULL
transactivated	NULL
this	NULL
LTR	NULL
about	NULL
twofold	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
small	NULL
component	NULL
of	NULL
CBF	NULL
activity	NULL
on	NULL
the	NULL
SL3	NULL
reporter	NULL
construct	NULL
in	NULL
HeLa	NULL
cells	NULL
was	NULL
independent	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

It	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
factor	NULL
acting	NULL
through	NULL
an	NULL
unknown	NULL
CBF	NULL
binding	NULL
site	NULL
elsewhere	NULL
in	NULL
the	NULL
SL3-CAT	NULL
plasmid	NULL
.	NULL

However	NULL
,	NULL
an	NULL
equivalent	NULL
effect	NULL
was	NULL
not	NULL
seen	NULL
in	NULL
P19	NULL
cells	NULL
.	NULL

An	NULL
alternative	NULL
explanation	NULL
is	NULL
that	NULL
CBFa2-451	NULL
may	NULL
have	NULL
induced	NULL
2902	NULL
ZAIMAN	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
SL3	NULL
AKV	NULL
J.	NULL
ViroL	NULL
.	NULL

HA	NULL
MUT	NULL
--	NULL
--	NULL
-	NULL
--	NULL
-	NULL
--	NULL
i	NULL
B	NULL
Percent	NULL
Bound	NULL
0	NULL
20	NULL
40	NULL
60	NULL
BD	NULL
100	NULL
Competitor	NULL
DNA	NULL
#	NULL
«	NULL
SL3	NULL
5'-GGATATCTGTGGTTAAGCA-3°	NULL
'	NULL
AKV	NULL
5'-GGATATCTGTGGTCAACCA-3	NULL
'	NULL
HA	NULL
5'-GGATATTTGCGGTTAGCA-3°	NULL
MUT	NULL
5'-GGATATCAGCCGTAAGCA-3°	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Competition	NULL
EMSA	NULL
with	NULL
£	NULL
.	NULL

coli-expressed	NULL
preparations	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
CBF	NULL
a	NULL
with	NULL
various	NULL
enhancer	NULL
core	NULL
sequences	NULL
.	NULL

(	NULL
A	NULL
)	NULL
A	NULL
radiolabeled	NULL
high-affinity-site	NULL
probe	NULL
was	NULL
used	NULL
in	NULL
EMSAs	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
each	NULL
competitor	NULL
oligonucleotide	NULL
were	NULL
added	NULL
as	NULL
indicated	NULL
(	NULL
HA	NULL
,	NULL
high-affinity	NULL
site	NULL
;	NULL
MUT	NULL
,	NULL
mutated	NULL
site	NULL
)	NULL
.	NULL

In	NULL
each	NULL
set	NULL
of	NULL
seven	NULL
lanes	NULL
from	NULL
left	NULL
to	NULL
right	NULL
,	NULL
the	NULL
competitors	NULL
were	NULL
present	NULL
at	NULL
0-	NULL
,	NULL
3-	NULL
,	NULL
6-	NULL
,	NULL
12-	NULL
,	NULL
25-	NULL
,	NULL
50-	NULL
,	NULL
and	NULL
100-fold	NULL
molar	NULL
excess	NULL
over	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Percentage	NULL
of	NULL
the	NULL
protein-DNA	NULL
complex	NULL
relative	NULL
to	NULL
that	NULL
with	NULL
no	NULL
added	NULL
competitor	NULL
DNA	NULL
versus	NULL
the	NULL
amount	NULL
of	NULL
competitor	NULL
DNA	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Sequences	NULL
of	NULL
one	NULL
strand	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
in	NULL
this	NULL
experiment	NULL
.	NULL

the	NULL
activity	NULL
of	NULL
some	NULL
other	NULL
factor	NULL
in	NULL
HeLa	NULL
cells	NULL
that	NULL
in	NULL
turn	NULL
increased	NULL
activity	NULL
of	NULL
the	NULL
SL3	NULL
promoter-CAT	NULL
construct	NULL
.	NULL

We	NULL
note	NULL
that	NULL
such	NULL
a	NULL
factor	NULL
would	NULL
not	NULL
be	NULL
active	NULL
on	NULL
every	NULL
transcription	NULL
unit	NULL
,	NULL
as	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
an	NULL
effect	NULL
on	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
enhancer/promoter-luciferase	NULL
plasmid	NULL
that	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
CBF	NULL
B	NULL
subunits	NULL
.	NULL

There	NULL
are	NULL
at	NULL
least	NULL
four	NULL
different	NULL
spliced	NULL
forms	NULL
of	NULL
CBF	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
are	NULL
named	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
predicted	NULL
number	NULL
of	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
encoded	NULL
product	NULL
.	NULL

Wang	NULL
et	NULL
al	NULL
.	NULL

(	NULL
50	NULL
)	NULL
and	NULL
Ogawa	NULL
et	NULL
al	NULL
.	NULL

(	NULL
33	NULL
)	NULL
each	NULL
identified	NULL
two	NULL
subunits	NULL
,	NULL
CBF	NULL
B-187	NULL
and	NULL
CBF	NULL
B-182	NULL
,	NULL
that	NULL
differ	NULL
at	NULL
their	NULL
carboxyl	NULL
termini	NULL
.	NULL

While	NULL
neither	NULL
CBF	NULL
B-187	NULL
nor	NULL
CBF	NULL
B-182	NULL
bound	NULL
to	NULL
DNA	NULL
directly	NULL
,	NULL
each	NULL
could	NULL
bind	NULL
to	NULL
CBF	NULL
a	NULL
subunits	NULL
through	NULL
the	NULL
Runt	NULL
domain	NULL
and	NULL
stimulate	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Wang	NULL
et	NULL
al	NULL
.	NULL

(	NULL
50	NULL
)	NULL
also	NULL
identified	NULL
a	NULL
third	NULL
CBF	NULL
f	NULL
isoform	NULL
termed	NULL
CBF	NULL
B-148	NULL
.	NULL

This	NULL
was	NULL
identical	NULL
CBF	NULL
B-187	NULL
except	NULL
for	NULL
an	NULL
internal	NULL
deletion	NULL
of	NULL
the	NULL
39	NULL
amino	NULL
acids	NULL
encoded	NULL
in	NULL
exon	NULL
3	NULL
due	NULL
to	NULL
alternative	NULL
splicing	NULL
.	NULL

Ogawa	NULL
et	NULL
al	NULL
.	NULL

(	NULL
33	NULL
)	NULL
identified	NULL
another	NULL
form	NULL
,	NULL
here	NULL
termed	NULL
CBF	NULL
B-155	NULL
,	NULL
that	NULL
also	NULL
differed	NULL
from	NULL
CBF	NULL
B-187	NULL
by	NULL
an	NULL
internal	NULL
deletion	NULL
due	NULL
to	NULL
alternative	NULL
splicing	NULL
;	NULL
however	NULL
,	NULL
the	NULL
missing	NULL
sequences	NULL
were	NULL
from	NULL
exon	NULL
5	NULL
.	NULL

Interestingly	NULL
,	NULL
neither	NULL
CBF	NULL
B-148	NULL
nor	NULL
CBF	NULL
B-155	NULL
could	NULL
bind	NULL
to	NULL
CBF	NULL
a	NULL
or	NULL
stimulate	NULL
its	NULL
DNA	NULL
binding	NULL
capacity	NULL
,	NULL
indicating	NULL
that	NULL
there	NULL
is	NULL
a	NULL
central	NULL
domain	NULL
of	NULL
CBF	NULL
B	NULL
that	NULL
is	NULL
important	NULL
for	NULL
CBF	NULL
«	NULL
binding	NULL
(	NULL
12	NULL
,	NULL
33	NULL
,	NULL
50	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
CBF	NULL
B	NULL
subunits	NULL
on	NULL
transcription	NULL
,	NULL
plasmids	NULL
encoding	NULL
CBF	NULL
B-187	NULL
,	NULL
CBF	NULL
B-182	NULL
,	NULL
and	NULL
CBF	NULL
B-148	NULL
were	NULL
tested	NULL
in	NULL
cotransfection	NULL
assays	NULL
using	NULL
HeLa	NULL
and	NULL
P19	NULL
cells	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
a	NULL
CBF	NULL
B	NULL
plasmid	NULL
were	NULL
co	NULL
12	NULL
10	NULL
SL3-CAT	NULL
%	NULL
Conversion	NULL
&	NULL
1	NULL
?	NULL

//	NULL
%	NULL
5	NULL
‘	NULL
i	NULL
,	NULL
ﬂf§-~\	NULL
%	NULL
SAA-CAT	NULL
0	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
1	NULL
o	NULL
1	NULL
2	NULL
3	NULL
4	NULL
s	NULL
ug	NULL
RSV-CBFo2-451	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
cotransfection	NULL
of	NULL
CBFa2-451	NULL
on	NULL
activity	NULL
of	NULL
the	NULL
SL3	NULL
and	NULL
SAA	NULL
LTRs	NULL
in	NULL
the	NULL
T-lymphocyte	NULL
line	NULL
L691	NULL
.	NULL

LTR-CAT	NULL
plasmid	NULL
DNA	NULL
(	NULL
3	NULL
pg	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
L691	NULL
cells	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
CBF	NULL
«	NULL
2-451	NULL
were	NULL
cotransfected	NULL
,	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
determined	NULL
.	NULL

Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
10	NULL
,	NULL
-	NULL
CBF	NULL
@	NULL
2-451	NULL
(	NULL
AML1	NULL
)	NULL
in	NULL
P19	NULL
Cells	NULL
Fold	NULL
Transactivation	NULL
14	NULL
I	NULL
I	NULL
_I—|	NULL
0	NULL
SL3	NULL
SAA	NULL
Core	NULL
I	NULL
-	NULL
Core	NULL
II	NULL
_	NULL
Both	NULL
Mut	NULL
.	NULL

Mut	NULL
.	NULL

Mut	NULL
.	NULL

Reporter	NULL
Plasmid	NULL
A1	NULL
TRANSCRIPTIONAL	NULL
ACTIVATION	NULL
OF	NULL
CBF	NULL
ON	NULL
THE	NULL
SL3	NULL
LTR	NULL
2903	NULL
CBF	NULL
«	NULL
2-451	NULL
(	NULL
AML1	NULL
)	NULL
in	NULL
HeLa	NULL
Cells	NULL
Fold	NULL
Transactivation	NULL
SL3	NULL
SAA	NULL
_	NULL
Core	NULL
I	NULL
_	NULL
Core	NULL
II	NULL
Both	NULL
Mut	NULL
Mut	NULL
.	NULL

Mut	NULL
.	NULL

Reporter	NULL
Plasmid	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Effects	NULL
of	NULL
mutation	NULL
of	NULL
the	NULL
SL3	NULL
cores	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
CBFa	NULL
«	NULL
2-451	NULL
to	NULL
transactivate	NULL
the	NULL
reporter	NULL
construct	NULL
.	NULL

The	NULL
indicated	NULL
reporters	NULL
were	NULL
cotransfected	NULL
with	NULL
CBFa2-451	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
transactivator	NULL
used	NULL
in	NULL
each	NULL
cell	NULL
line	NULL
was	NULL
based	NULL
on	NULL
the	NULL
titration	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

In	NULL
P19	NULL
cells	NULL
,	NULL
0.5	NULL
ug	NULL
of	NULL
CBFa2-451	NULL
was	NULL
used	NULL
;	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
4	NULL
pg	NULL
was	NULL
used	NULL
.	NULL

The	NULL
means	NULL
of	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
transfections	NULL
for	NULL
each	NULL
experiment	NULL
are	NULL
plotted	NULL
,	NULL
and	NULL
the	NULL
error	NULL
bars	NULL
indicate	NULL
standard	NULL
deviations	NULL
.	NULL

transfected	NULL
with	NULL
the	NULL
CBFa2-451-encoding	NULL
plasmid	NULL
and	NULL
the	NULL
LTR-CAT	NULL
plasmid	NULL
.	NULL

Upon	NULL
the	NULL
addition	NULL
of	NULL
CBF	NULL
B-187	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
a	NULL
twofold	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
transactivation	NULL
over	NULL
that	NULL
of	NULL
CBFa2-451	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
required	NULL
the	NULL
CBF	NULL
a	NULL
subunit	NULL
,	NULL
as	NULL
CBF	NULL
B-187	NULL
did	NULL
not	NULL
enhance	NULL
transcription	NULL
by	NULL
itself	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
its	NULL
activity	NULL
also	NULL
depended	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
core	NULL
elements	NULL
in	NULL
the	NULL
SL3	NULL
enhancer	NULL
,	NULL
as	NULL
no	NULL
effects	NULL
of	NULL
the	NULL
CBF	NULL
B-187	NULL
were	NULL
observed	NULL
when	NULL
either	NULL
core	NULL
was	NULL
mutated	NULL
.	NULL

Thus	NULL
,	NULL
at	NULL
least	NULL
in	NULL
this	NULL
system	NULL
,	NULL
it	NULL
appeared	NULL
that	NULL
CBF	NULL
B	NULL
functioned	NULL
only	NULL
when	NULL
CBFae2-451	NULL
could	NULL
bind	NULL
to	NULL
both	NULL
sites	NULL
in	NULL
one	NULL
repeat	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
whether	NULL
CBF	NULL
B-187	NULL
could	NULL
affect	NULL
the	NULL
ability	NULL
of	NULL
CBFa2-451	NULL
to	NULL
distinguish	NULL
the	NULL
single	NULL
base	NULL
pair	NULL
difference	NULL
between	NULL
the	NULL
SL3	NULL
and	NULL
Akv	NULL
cores	NULL
.	NULL

Transcription	NULL
was	NULL
stimulated	NULL
about	NULL
twofold	NULL
when	NULL
the	NULL
T	NULL
in	NULL
the	NULL
SL3	NULL
core	NULL
I	NULL
was	NULL
mutated	NULL
to	NULL
the	NULL
C	NULL
in	NULL
Akyv	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
addition	NULL
of	NULL
CBF	NULL
B-187	NULL
did	NULL
not	NULL
allow	NULL
N-term	NULL
.	NULL

C-term	NULL
1	NULL
58	NULL
96	NULL
136	NULL
168	NULL
-	NULL
189	NULL
B-187	NULL
___	NULL
T	NULL
___	NULL
OJ	NULL
inv	NULL
B-182	NULL
B-148	NULL
L	NULL
1	NULL
58	NULL
96	NULL
195	NULL
168	NULL
189	NULL
_	NULL
m	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Schematic	NULL
diagram	NULL
of	NULL
various	NULL
spliced	NULL
forms	NULL
of	NULL
CBF	NULL
B	NULL
.	NULL

The	NULL
amino	NULL
and	NULL
carboxyl	NULL
termini	NULL
are	NULL
indicated	NULL
.	NULL

All	NULL
forms	NULL
are	NULL
compared	NULL
with	NULL
CBF	NULL
B-187	NULL
.	NULL

The	NULL
numbers	NULL
over	NULL
the	NULL
different	NULL
forms	NULL
indicate	NULL
the	NULL
corresponding	NULL
amino	NULL
acid	NULL
positions	NULL
in	NULL
CBF	NULL
B-187	NULL
.	NULL

The	NULL
empty	NULL
spaces	NULL
show	NULL
the	NULL
internal	NULL
deletions	NULL
found	NULL
in	NULL
CBF	NULL
B-148	NULL
and	NULL
CBF	NULL
8-155	NULL
,	NULL
while	NULL
the	NULL
hatched	NULL
box	NULL
at	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
CBF	NULL
B-182	NULL
indicates	NULL
different	NULL
amino	NULL
acids	NULL
at	NULL
this	NULL
position	NULL
.	NULL

CBFa2-451	NULL
to	NULL
discriminate	NULL
between	NULL
the	NULL
SL3	NULL
and	NULL
Akv	NULL
core	NULL
sites	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
CBF	NULL
B-182	NULL
form	NULL
of	NULL
CBF	NULL
B	NULL
was	NULL
less	NULL
clear	NULL
.	NULL

CBF	NULL
B-182	NULL
appeared	NULL
to	NULL
stimulate	NULL
transcription	NULL
less	NULL
well	NULL
than	NULL
CBF	NULL
B-187	NULL
but	NULL
better	NULL
than	NULL
CBFa2-451	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
highly	NULL
reproducible	NULL
,	NULL
as	NULL
it	NULL
was	NULL
seen	NULL
in	NULL
every	NULL
trial	NULL
that	NULL
we	NULL
performed	NULL
,	NULL
regardless	NULL
of	NULL
whether	NULL
the	NULL
SL3	NULL
or	NULL
Akv	NULL
core	NULL
sequence	NULL
was	NULL
present	NULL
in	NULL
the	NULL
reporter	NULL
construct	NULL
.	NULL

However	NULL
,	NULL
since	NULL
the	NULL
level	NULL
of	NULL
stimulation	NULL
in	NULL
some	NULL
experiments	NULL
was	NULL
only	NULL
about	NULL
1.5-fold	NULL
greater	NULL
than	NULL
activity	NULL
of	NULL
CBFa2-451	NULL
alone	NULL
,	NULL
we	NULL
are	NULL
uncertain	NULL
whether	NULL
this	NULL
effect	NULL
is	NULL
significant	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

CBF	NULL
B-148	NULL
failed	NULL
to	NULL
stimulate	NULL
transcription	NULL
relative	NULL
to	NULL
CBFa2-451	NULL
alone	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
inability	NULL
of	NULL
this	NULL
form	NULL
of	NULL
CBF	NULL
B	NULL
to	NULL
associate	NULL
with	NULL
CBF	NULL
a	NULL
in	NULL
vitro	NULL
(	NULL
50	NULL
)	NULL
.	NULL

When	NULL
CBF	NULL
B	NULL
subunits	NULL
were	NULL
coexpressed	NULL
with	NULL
CBFa2-451	NULL
in	NULL
P19	NULL
cells	NULL
,	NULL
no	NULL
stimulation	NULL
of	NULL
transcription	NULL
was	NULL
seen	NULL
,	NULL
even	NULL
with	NULL
CBF	NULL
B-187	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
CBF	NULL
$	NULL
differ	NULL
between	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
.	NULL

We	NULL
do	NULL
not	NULL
know	NULL
the	NULL
basis	NULL
for	NULL
this	NULL
difference	NULL
.	NULL

It	NULL
might	NULL
be	NULL
the	NULL
result	NULL
of	NULL
different	NULL
endogenous	NULL
levels	NULL
of	NULL
the	NULL
B	NULL
subunits	NULL
or	NULL
differences	NULL
in	NULL
the	NULL
ratios	NULL
of	NULL
the	NULL
different	NULL
spliced	NULL
forms	NULL
in	NULL
the	NULL
two	NULL
lines	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
effect	NULL
may	NULL
be	NULL
the	NULL
result	NULL
of	NULL
some	NULL
additional	NULL
cofactor	NULL
that	NULL
might	NULL
be	NULL
required	NULL
for	NULL
CBF	NULL
B	NULL
activity	NULL
and	NULL
is	NULL
specific	NULL
for	NULL
one	NULL
of	NULL
the	NULL
two	NULL
lines	NULL
.	NULL

DISCUSSION	NULL
Our	NULL
results	NULL
demonstrate	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
AML1-encoded	NULL
CBF	NULL
a	NULL
and	NULL
CBF	NULL
B	NULL
on	NULL
the	NULL
core	NULL
elements	NULL
from	NULL
two	NULL
MuLVs	NULL
,	NULL
SL3	NULL
and	NULL
Akv	NULL
.	NULL

They	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
idea	NULL
that	NULL
CBF	NULL
is	NULL
a	NULL
factor	NULL
in	NULL
T	NULL
cells	NULL
that	NULL
is	NULL
responsible	NULL
for	NULL
recognition	NULL
of	NULL
the	NULL
viral	NULL
cores	NULL
.	NULL

CBF	NULL
also	NULL
binds	NULL
to	NULL
the	NULL
core	NULL
elements	NULL
within	NULL
the	NULL
LTR	NULL
enhancers	NULL
of	NULL
other	NULL
mammalian	NULL
type	NULL
C	NULL
retroviruses	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
CBF	NULL
will	NULL
function	NULL
on	NULL
the	NULL
other	NULL
MuLV	NULL
cores	NULL
.	NULL

Mutations	NULL
within	NULL
the	NULL
SL3	NULL
core	NULL
element	NULL
strongly	NULL
affect	NULL
viral	NULL
leukemogenicity	NULL
(	NULL
13	NULL
,	NULL
29	NULL
)	NULL
.	NULL

This	NULL
can	NULL
be	NULL
interpreted	NULL
to	NULL
mean	NULL
that	NULL
2904	NULL
ZAIMAN	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

SL3-CAT	NULL
Mutated	NULL
Core	NULL
I	NULL
Mutated	NULL
Core	NULL
II	NULL
16	NULL
16	NULL
14	NULL
4	NULL
16	NULL
14	NULL
C	NULL
14	NULL
T	NULL
5	NULL
80	NULL
+4	NULL
5	NULL
iz	NULL
-§	NULL
12	NULL
g	NULL
E=	NULL
A	NULL
o	NULL
g	NULL
j-	NULL
$	NULL
ao	NULL
f	NULL
10	NULL
@	NULL
1	NULL
g	NULL
E	NULL
8	NULL
4	NULL
a	NULL
+	NULL
C	NULL
s	NULL
©oos	NULL
``	NULL
I	NULL
'	NULL
kel	NULL
g	NULL
;	NULL
P	NULL
£05	NULL
€	NULL
s	NULL
|	NULL
I	NULL
.	NULL

a	NULL
4	NULL
a	NULL
1	NULL
o	NULL
0	NULL
CBFo2	NULL
CBF	NULL
CBFoZ	NULL
CBFo2	NULL
$	NULL
-187	NULL
CBFaZ	NULL
CBFo2	NULL
CBFoZ	NULL
CBFa2	NULL
B-187	NULL
CBFo2	NULL
CBFo2	NULL
CBFo2	NULL
CBFoZ	NULL
§-187	NULL
6-188	NULL
$	NULL
-182	NULL
8-148	NULL
-	NULL
alone	NULL
|	NULL
6-182	NULL
6-148	NULL
-	NULL
alone	NULL
B-188	NULL
|	NULL
6.482	NULL
-	NULL
6-148	NULL
-	NULL
alone	NULL
SAA-CAT	NULL
Mutated	NULL
16	NULL
Core	NULL
I	NULL
&	NULL
Core	NULL
II	NULL
14	NULL
4	NULL
20	NULL
C	NULL
g	NULL
18	NULL
‘	NULL
|	NULL
'	NULL
12-4	NULL
g	NULL
§	NULL
as	NULL
a	NULL
S	NULL
I.	NULL
l	NULL
:	NULL
8	NULL
4	NULL
g	NULL
12	NULL
l	NULL
x	NULL
©	NULL
0	NULL
ao	NULL
$	NULL
.	NULL

C	NULL
|	NULL
3	NULL
c	NULL
1	NULL
24	NULL
m	NULL
0	NULL
CBFo2Z	NULL
CBFoZ	NULL
CBFoZ	NULL
CBFoZ	NULL
8-187	NULL
6-188	NULL
8-182	NULL
$	NULL
-148	NULL
alone	NULL
o	NULL
no	NULL
a	NULL
a	NULL
o	NULL
CBFa2	NULL
CBFoZ	NULL
CBFo2	NULL
CBFoZ	NULL
g-188	NULL
g-182	NULL
.	NULL

A-148	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Effects	NULL
of	NULL
the	NULL
multiple	NULL
forms	NULL
of	NULL
CBF	NULL
§	NULL
in	NULL
cotransfection	NULL
experiments	NULL
with	NULL
each	NULL
of	NULL
the	NULL
reporter	NULL
plasmids	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Each	NULL
panel	NULL
shows	NULL
a	NULL
specific	NULL
reporter	NULL
construct	NULL
.	NULL

The	NULL
CBF	NULL
subunits	NULL
used	NULL
in	NULL
each	NULL
experiment	NULL
are	NULL
indicated	NULL
along	NULL
the	NULL
x	NULL
axis	NULL
of	NULL
each	NULL
panel	NULL
.	NULL

When	NULL
a	NULL
single	NULL
CBF	NULL
subunit	NULL
was	NULL
tested	NULL
,	NULL
2.5	NULL
pg	NULL
of	NULL
the	NULL
plasmid	NULL
encoding	NULL
it	NULL
plus	NULL
2.5	NULL
ug	NULL
of	NULL
pBluescript	NULL
(	NULL
SK+	NULL
)	NULL
were	NULL
used	NULL
.	NULL

When	NULL
plasmids	NULL
encoding	NULL
both	NULL
CBF	NULL
subunits	NULL
were	NULL
transfected	NULL
together	NULL
,	NULL
2.5	NULL
ug	NULL
of	NULL
each	NULL
was	NULL
used	NULL
.	NULL

The	NULL
graphs	NULL
present	NULL
the	NULL
means	NULL
of	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
transfections	NULL
for	NULL
cach	NULL
experiment	NULL
.	NULL

The	NULL
error	NULL
bars	NULL
indicate	NULL
standard	NULL
deviations	NULL
.	NULL

the	NULL
transcriptional	NULL
activity	NULL
of	NULL
CBF	NULL
on	NULL
the	NULL
SL3	NULL
enhancer	NULL
is	NULL
important	NULL
for	NULL
one	NULL
or	NULL
more	NULL
steps	NULL
in	NULL
the	NULL
viral	NULL
leukemogenic	NULL
process	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

However	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
SL3	NULL
core	NULL
I	NULL
to	NULL
that	NULL
of	NULL
Akyv	NULL
significantly	NULL
reduced	NULL
both	NULL
the	NULL
transcriptional	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
capacity	NULL
to	NULL
induce	NULL
T-cell	NULL
lymphomas	NULL
(	NULL
4	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
surprising	NULL
that	NULL
CBF	NULL
«	NULL
2-451	NULL
transactivated	NULL
both	NULL
viral	NULL
cores	NULL
to	NULL
the	NULL
same	NULL
level	NULL
.	NULL

Binding	NULL
assays	NULL
have	NULL
indicated	NULL
that	NULL
CBF	NULL
binds	NULL
the	NULL
SL3	NULL
core	NULL
better	NULL
than	NULL
that	NULL
of	NULL
Akyv	NULL
(	NULL
24	NULL
,	NULL
47	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
does	NULL
bind	NULL
the	NULL
Akv	NULL
sequence	NULL
(	NULL
4	NULL
,	NULL
22	NULL
,	NULL
24	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Binding	NULL
assays	NULL
presented	NULL
here	NULL
indicated	NULL
that	NULL
CBF	NULL
bound	NULL
the	NULL
SL3	NULL
core	NULL
approximately	NULL
two	NULL
times	NULL
better	NULL
than	NULL
the	NULL
Akv	NULL
core	NULL
.	NULL

The	NULL
key	NULL
question	NULL
is	NULL
whether	NULL
this	NULL
difference	NULL
in	NULL
binding	NULL
is	NULL
important	NULL
for	NULL
the	NULL
differential	NULL
transcription	NULL
of	NULL
the	NULL
two	NULL
cores	NULL
.	NULL

CBF	NULL
may	NULL
still	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
ability	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
distinguish	NULL
the	NULL
SL3	NULL
and	NULL
Akv	NULL
cores	NULL
,	NULL
despite	NULL
the	NULL
observation	NULL
that	NULL
CBFa2-451	NULL
transactivated	NULL
both	NULL
viral	NULL
cores	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
in	NULL
the	NULL
cotransfection	NULL
assays	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
cotransfection	NULL
assays	NULL
do	NULL
not	NULL
fully	NULL
reflect	NULL
the	NULL
conditions	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
additional	NULL
factors	NULL
in	NULL
T	NULL
cells	NULL
that	NULL
bind	NULL
the	NULL
SL3	NULL
enhancer	NULL
may	NULL
modulate	NULL
the	NULL
ability	NULL
of	NULL
CBF	NULL
to	NULL
distinguish	NULL
the	NULL
T-C	NULL
difference	NULL
between	NULL
the	NULL
two	NULL
viral	NULL
cores	NULL
.	NULL

Indeed	NULL
,	NULL
previous	NULL
data	NULL
indicated	NULL
that	NULL
sequences	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
core	NULL
element	NULL
in	NULL
the	NULL
SL3	NULL
enhancer	NULL
sequences	NULL
were	NULL
important	NULL
for	NULL
T	NULL
cells	NULL
to	NULL
distinguish	NULL
the	NULL
two	NULL
cores	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
absence	NULL
of	NULL
one	NULL
of	NULL
these	NULL
factors	NULL
in	NULL
HeLa	NULL
or	NULL
P19	NULL
cells	NULL
may	NULL
prevent	NULL
CBF	NULL
from	NULL
differentiating	NULL
the	NULL
viral	NULL
cores	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
the	NULL
preferential	NULL
recognition	NULL
of	NULL
the	NULL
SL3	NULL
core	NULL
is	NULL
actually	NULL
mediated	NULL
by	NULL
a	NULL
transcription	NULL
factor	NULL
other	NULL
than	NULL
CBF	NULL
.	NULL

At	NULL
least	NULL
two	NULL
other	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
MuLV	NULL
core	NULL
elements	NULL
,	NULL
S-CBF	NULL
and	NULL
MCREF-1	NULL
(	NULL
4	NULL
,	NULL
23	NULL
,	NULL
44	NULL
)	NULL
,	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

If	NULL
either	NULL
of	NULL
these	NULL
factors	NULL
is	NULL
actually	NULL
important	NULL
for	NULL
distinguishing	NULL
the	NULL
SL3	NULL
and	NULL
Akyv	NULL
cores	NULL
,	NULL
it	NULL
would	NULL
be	NULL
necessary	NULL
to	NULL
explain	NULL
how	NULL
they	NULL
can	NULL
act	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CBF	NULL
.	NULL

Perhaps	NULL
CBF	NULL
somehow	NULL
works	NULL
in	NULL
combination	NULL
with	NULL
one	NULL
or	NULL
more	NULL
additional	NULL
core	NULL
binding	NULL
factors	NULL
.	NULL

A	NULL
full	NULL
description	NULL
of	NULL
how	NULL
transcription	NULL
factors	NULL
in	NULL
T	NULL
lymphocytes	NULL
recognize	NULL
MuLV	NULL
enhancers	NULL
must	NULL
account	NULL
for	NULL
two	NULL
obser-vations	NULL
.	NULL

One	NULL
is	NULL
the	NULL
ability	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
distinguish	NULL
the	NULL
SL3	NULL
and	NULL
Akv	NULL
cores	NULL
.	NULL

The	NULL
other	NULL
is	NULL
that	NULL
CBF	NULL
is	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
and	NULL
at	NULL
least	NULL
certain	NULL
combinations	NULL
of	NULL
CBF	NULL
«	NULL
and	NULL
CBF	NULL
B	NULL
are	NULL
transcriptionally	NULL
active	NULL
on	NULL
both	NULL
the	NULL
SL3	NULL
and	NULL
Akv	NULL
enhancer	NULL
cores	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
showed	NULL
that	NULL
the	NULL
CBF	NULL
B-187	NULL
form	NULL
of	NULL
CBF	NULL
B	NULL
had	NULL
transcriptional	NULL
activity	NULL
.	NULL

The	NULL
CBF	NULL
B-182	NULL
form	NULL
also	NULL
repro-ducibly	NULL
stimulated	NULL
transcription	NULL
to	NULL
a	NULL
lower	NULL
level	NULL
than	NULL
CBF	NULL
B-187	NULL
,	NULL
although	NULL
the	NULL
effect	NULL
was	NULL
small	NULL
and	NULL
difficult	NULL
to	NULL
measure	NULL
.	NULL

The	NULL
lower	NULL
activity	NULL
of	NULL
CBF	NULL
B-182	NULL
did	NULL
suggest	NULL
that	NULL
the	NULL
carboxyl-terminal	NULL
amino	NULL
acids	NULL
that	NULL
distinguish	NULL
CBF	NULL
B-187	NULL
from	NULL
CBF	NULL
B-182	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
have	NULL
a	NULL
modest	NULL
effect	NULL
on	NULL
transcription	NULL
.	NULL

These	NULL
amino	NULL
acids	NULL
are	NULL
replaced	NULL
by	NULL
smooth	NULL
muscle	NULL
myosin	NULL
heavy-chain	NULL
sequences	NULL
in	NULL
human	NULL
AML	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
core	NULL
site	NULL
dependence	NULL
of	NULL
CBF	NULL
B	NULL
transcriptional	NULL
activity	NULL
was	NULL
consistent	NULL
with	NULL
a	NULL
requirement	NULL
for	NULL
it	NULL
to	NULL
work	NULL
by	NULL
binding	NULL
to	NULL
CBF	NULL
«	NULL
.	NULL

CBF	NULL
B	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
stimulate	NULL
the	NULL
ability	NULL
of	NULL
CBF	NULL
«	NULL
to	NULL
bind	NULL
DNA	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Transcriptional	NULL
stimulation	NULL
by	NULL
CBF	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
B	NULL
may	NULL
simply	NULL
reflect	NULL
this	NULL
property	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
curious	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
CBF	NULL
B	NULL
was	NULL
seen	NULL
only	NULL
when	NULL
both	NULL
core	NULL
elements	NULL
within	NULL
each	NULL
72-bp	NULL
repeat	NULL
in	NULL
the	NULL
SL3	NULL
enhancer	NULL
were	NULL
intact	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
stimulation	NULL
by	NULL
CBF	NULL
B-187	NULL
on	NULL
enhancers	NULL
with	NULL
one	NULL
of	NULL
the	NULL
two	NULL
cores	NULL
mutated	NULL
was	NULL
too	NULL
small	NULL
to	NULL
be	NULL
detected	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
CBF	NULL
B-187	NULL
can	NULL
stimulate	NULL
transcription	NULL
only	NULL
when	NULL
all	NULL
four	NULL
binding	NULL
sites	NULL
are	NULL
intact	NULL
.	NULL

Perhaps	NULL
it	NULL
has	NULL
an	NULL
additional	NULL
function	NULL
beyond	NULL
the	NULL
stimulation	NULL
of	NULL
CBF	NULL
a	NULL
binding	NULL
.	NULL

Whatever	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
,	NULL
the	NULL
maximum	NULL
activity	NULL
of	NULL
CBF	NULL
in	NULL
HeLa	NULL
cells	NULL
required	NULL
both	NULL
subunits	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
activity	NULL
on	NULL
the	NULL
core	NULL
elements	NULL
of	NULL
two	NULL
MuLV	NULL
enhancers	NULL
,	NULL
CBF	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
function	NULL
on	NULL
the	NULL
enhancer	NULL
of	NULL
the	NULL
TCR	NULL
B	NULL
chain	NULL
(	NULL
2	NULL
,	NULL
34	NULL
)	NULL
.	NULL

As	NULL
similar	NULL
sequences	NULL
are	NULL
present	NULL
in	NULL
the	NULL
enhancers	NULL
of	NULL
many	NULL
lymphoid	NULL
cell-specific	NULL
genes	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
this	NULL
factor	NULL
regulates	NULL
the	NULL
transcription	NULL
of	NULL
many	NULL
lymphoid	NULL
genes	NULL
.	NULL

CBF	NULL
binding	NULL
activity	NULL
is	NULL
also	NULL
present	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

Its	NULL
potential	NULL
role	NULL
in	NULL
these	NULL
cells	NULL
remains	NULL
to	NULL
be	NULL
investigated	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
grants	NULL
CA44822	NULL
and	NULL
CA57337	NULL
to	NULL
J.L	NULL
.	NULL

and	NULL
CA51065	NULL
to	NULL
N.A.S	NULL
.	NULL

J.L	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
Hirschl-Caulier	NULL
career	NULL
scientist	NULL
award	NULL
.	NULL

N.A.S	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
an	NULL
American	NULL
Cancer	NULL
Society	NULL
junior	NULL
faculty	NULL
research	NULL
award	NULL
.	NULL

A.L.Z	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
training	NULL
grant	NULL
GM7288	NULL
.	NULL

B.E.C	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
training	NULL
grant	NULL
AI-07363	NULL
.	NULL

Synthesis	NULL
of	NULL
oligonucleotides	NULL
and	NULL
PhosphorImager	NULL
analysis	NULL
were	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
Cancer	NULL
Center	NULL
grant	NULL
CA13330	NULL
to	NULL
the	NULL
Albert	NULL
Einstein	NULL
College	NULL
of	NULL
Medicine	NULL
.	NULL

We	NULL
thank	NULL
R.	NULL
DePinho	NULL
for	NULL
the	NULL
P19	NULL
cells	NULL
and	NULL
G.	NULL
Childs	NULL
,	NULL
J.	NULL
Dudley	NULL
,	NULL
and	NULL
R.	NULL
Kitsis	NULL
for	NULL
the	NULL
luciferase	NULL
plasmids	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Bae	NULL
,	NULL
S.	NULL
,	NULL
E.	NULL
Takahashi	NULL
,	NULL
Y.	NULL
W.	NULL
Zhang	NULL
,	NULL
E.	NULL
Ogawa	NULL
,	NULL
K.	NULL
Shigesada	NULL
,	NULL
Y.	NULL
Namba	NULL
,	NULL
M.	NULL
Satake	NULL
,	NULL
and	NULL
Y.	NULL
Ito	NULL
.	NULL

Cloning	NULL
,	NULL
mapping	NULL
and	NULL
expression	NULL
of	NULL
PEBP2	NULL
«	NULL
C	NULL
,	NULL
a	NULL
third	NULL
gene	NULL
encoding	NULL
the	NULL
mammalian	NULL
Runt	NULL
domain	NULL
.	NULL

Gene	NULL
,	NULL
in	NULL
press	NULL
.	NULL

2	NULL
.	NULL

Bae	NULL
,	NULL
S.-C.	NULL
,	NULL
E.	NULL
Ogawa	NULL
,	NULL
M.	NULL
Maruyama	NULL
,	NULL
H.	NULL
Oka	NULL
,	NULL
M.	NULL
Satake	NULL
,	NULL
K.	NULL
Shigesada	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
D.	NULL
J.	NULL
Gilbert	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
and	NULL
Y.	NULL
Ito	NULL
.	NULL

1994	NULL
.	NULL

PEBP2	NULL
«	NULL
B/mouse	NULL
AML1	NULL
consists	NULL
of	NULL
multiple	NULL
isoforms	NULL
that	NULL
possess	NULL
differential	NULL
transactivation	NULL
potentials	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:3242-3252	NULL
.	NULL

3	NULL
.	NULL

Bae	NULL
,	NULL
S	NULL
C	NULL
Y.	NULL
Yamaguchl	NULL
Iwai	NULL
,	NULL
E.	NULL
Ogawa	NULL
,	NULL
M.	NULL
Maruyama	NULL
,	NULL
M.	NULL
Inuzuka	NULL
,	NULL
H.	NULL
K	NULL
K.	NULL
Shi	NULL
M.	NULL
Satake	NULL
,	NULL
and	NULL
Y.	NULL
Ito	NULL
.	NULL

1993	NULL
.	NULL

Isolation	NULL
of	NULL
cDNA	NULL
rcprescntmg	NULL
the	NULL
mouse	NULL
homolog	NULL
of	NULL
human	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
gene	NULL
,	NULL
AML1	NULL
.	NULL

Oncogene	NULL
8:809-814	NULL
.	NULL

4	NULL
.	NULL

Boral	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
S.	NULL
A.	NULL
Okenquist	NULL
,	NULL
and	NULL
J.	NULL
Lenz	NULL
.	NULL

1989	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
SL3-3	NULL
virus	NULL
enhancer	NULL
core	NULL
as	NULL
a	NULL
T-lymphoma	NULL
cell-specific	NULL
element	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:76-84	NULL
.	NULL

5	NULL
.	NULL

Brasier	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
J.	NULL
E.	NULL
Tate	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Habener	NULL
.	NULL

1989	NULL
.	NULL

Optimized	NULL
use	NULL
of	NULL
the	NULL
firefly	NULL
luciferase	NULL
assay	NULL
as	NULL
a	NULL
reporter	NULL
gene	NULL
in	NULL
mammalian	NULL
cell	NULL
lines	NULL
.	NULL

BioTech-niques	NULL
7:1116-1122	NULL
.	NULL

6	NULL
.	NULL

Cameron	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
S.	NULL
Taylor	NULL
,	NULL
E.	NULL
C.	NULL
TePas	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
and	NULL
B.	NULL
Mathey-Prevot	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
critical	NULL
regulatory	NULL
site	NULL
in	NULL
the	NULL
human	NULL
interleukin-3	NULL
promoter	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
.	NULL

Blood	NULL
83:2851-2859	NULL
.	NULL

7	NULL
.	NULL

Crute	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Speck	NULL
.	NULL

1994	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

8	NULL
.	NULL

Daga	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
E.	NULL
Tighe	NULL
,	NULL
and	NULL
F.	NULL
Calabi	NULL
.	NULL

1992	NULL
.	NULL

Leukaemia/Drosophila	NULL
homology	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
356:484	NULL
.	NULL

9	NULL
.	NULL

Erickson	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
Gao	NULL
,	NULL
K.-S.	NULL
Chang	NULL
,	NULL
T.	NULL
Look	NULL
,	NULL
E.	NULL
Whisenant	NULL
,	NULL
S.	NULL
Raimondi	NULL
,	NULL
R.	NULL
Lasher	NULL
,	NULL
J.	NULL
Trujillo	NULL
,	NULL
J.	NULL
Rowley	NULL
,	NULL
and	NULL
H.	NULL
Drabkin	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
breakpoints	NULL
in	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
and	NULL
isolation	NULL
of	NULL
a	NULL
fusion	NULL
transcript	NULL
,	NULL
AMLI/ETO	NULL
,	NULL
with	NULL
similarity	NULL
to	NULL
Drosophila	NULL
segmentation	NULL
gene	NULL
,	NULL
runt	NULL
.	NULL

Blood	NULL
80:1825-1831	NULL
.	NULL

10	NULL
.	NULL

Golemis	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
and	NULL
N.	NULL
Hopkins	NULL
.	NULL

1990	NULL
.	NULL

Alignment	NULL
of	NULL
U3	NULL
region	NULL
sequences	NULL
of	NULL
mammalian	NULL
type	NULL
C	NULL
viruses	NULL
:	NULL
identification	NULL
of	NULL
highly	NULL
conserved	NULL
motifs	NULL
and	NULL
implications	NULL
for	NULL
enhancer	NULL
design	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:534-542	NULL
.	NULL

11	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
L.	NULL
F.	NULL
Moffat	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyltransferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

21044-1051	NULL
.	NULL

12	NULL
.	NULL

Hajra	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Liu	NULL
,	NULL
Q.	NULL
Wang	NULL
,	NULL
C.	NULL
A.	NULL
Kelley	NULL
,	NULL
T.	NULL
Stacy	NULL
,	NULL
R.	NULL
S.	NULL
Adelstein	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
and	NULL
F.	NULL
S.	NULL
Collins	NULL
.	NULL

The	NULL
leukemic	NULL
core-binding	NULL
factor	NULL
(	NULL
CBFB	NULL
)	NULL
smooth	NULL
muscle	NULL
myosin	NULL
heavy	NULL
chain	NULL
chimeric	NULL
protein	NULL
requires	NULL
both	NULL
CBFB	NULL
and	NULL
myosin	NULL
heavy	NULL
chain	NULL
domains	NULL
for	NULL
transformation	NULL
of	NULL
NIH	NULL
3T3	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
in	NULL
press	NULL
.	NULL

13	NULL
.	NULL

Hallberg	NULL
,	NULL
B.	NULL
,	NULL
J.	NULL
Schmidt	NULL
,	NULL
A.	NULL
Luz	NULL
,	NULL
F.	NULL
S.	NULL
Pedersen	NULL
,	NULL
and	NULL
T.	NULL
Grundstrim	NULL
.	NULL

1991	NULL
.	NULL

SL3-3	NULL
enhancer	NULL
factor	NULL
1	NULL
transcriptional	NULL
activators	NULL
are	NULL
required	NULL
for	NULL
tumor	NULL
formation	NULL
by	NULL
SL3-3	NULL
murine	NULL
leukemia	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:4177-4181	NULL
.	NULL

TRANSCRIPTIONAL	NULL
ACTIVATION	NULL
OF	NULL
CBF	NULL
ON	NULL
THE	NULL
SL3	NULL
LTR	NULL
2905	NULL
14	NULL
.	NULL

Hallberg	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
Thornell	NULL
,	NULL
M.	NULL
Holm	NULL
,	NULL
and	NULL
T.	NULL
Grundstrim	NULL
.	NULL

1992	NULL
.	NULL

SEF1	NULL
binding	NULL
is	NULL
important	NULL
for	NULL
T	NULL
cell	NULL
specific	NULL
enhancers	NULL
of	NULL
genes	NULL
for	NULL
T	NULL
cell	NULL
receptor-CD3	NULL
subunits	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:6495-6499	NULL
.	NULL

15	NULL
.	NULL

Hsiang	NULL
,	NULL
Y.	NULL
H.	NULL
,	NULL
D.	NULL
Spencer	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Raulet	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
role	NULL
of	NULL
viral	NULL
enhancer	NULL
``	NULL
core	NULL
``	NULL
motif-related	NULL
sequences	NULL
in	NULL
regulating	NULL
T	NULL
cell	NULL
receptor-y	NULL
and	NULL
-8	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:3905-3916	NULL
.	NULL

16	NULL
.	NULL

Kagoshima	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Shigesada	NULL
,	NULL
M.	NULL
Satake	NULL
,	NULL
Y.	NULL
Ito	NULL
,	NULL
H.	NULL
Miyoshi	NULL
,	NULL
M.	NULL
Ohki	NULL
,	NULL
M.	NULL
Pepling	NULL
,	NULL
and	NULL
P.	NULL
Gergen	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
Runt	NULL
domain	NULL
identifies	NULL
a	NULL
new	NULL
family	NULL
of	NULL
heteromeric	NULL
transcriptional	NULL
regulators	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

9:338-341	NULL
.	NULL

17	NULL
.	NULL

Kamachi	NULL
,	NULL
Y.	NULL
,	NULL
E.	NULL
Ogawa	NULL
,	NULL
M.	NULL
Asano	NULL
,	NULL
S.	NULL
Ishida	NULL
,	NULL
Y.	NULL
Murakami	NULL
,	NULL
M.	NULL
Satake	NULL
,	NULL
Y.	NULL
Ito	NULL
,	NULL
and	NULL
K.	NULL
Shigesada	NULL
.	NULL

1990	NULL
.	NULL

Purification	NULL
of	NULL
a	NULL
mouse	NULL
nuclear	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
both	NULL
the	NULL
A	NULL
and	NULL
B	NULL
cores	NULL
of	NULL
the	NULL
polyomavirus	NULL
enhancer	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:4808-4819	NULL
.	NULL

18	NULL
.	NULL

Khoury	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
P.	NULL
Gruss	NULL
.	NULL

1983	NULL
.	NULL

Enhancer	NULL
elements	NULL
.	NULL

Cell	NULL
33:313-314	NULL
.	NULL

19	NULL
.	NULL

Lenz	NULL
,	NULL
J.	NULL
,	NULL
D.	NULL
Celander	NULL
,	NULL
R.	NULL
L.	NULL
Crowther	NULL
,	NULL
R.	NULL
Patarca	NULL
,	NULL
D.	NULL
W.	NULL
Perkins	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1984	NULL
.	NULL

Determination	NULL
of	NULL
the	NULL
leukemogenicity	NULL
of	NULL
a	NULL
murine	NULL
retrovirus	NULL
by	NULL
sequences	NULL
within	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
308:467-470	NULL
.	NULL

20	NULL
.	NULL

Levanon	NULL
,	NULL
D.	NULL
,	NULL
V.	NULL
Negreanu	NULL
,	NULL
Y.	NULL
Bernstein	NULL
,	NULL
I.	NULL
Bar-Am	NULL
,	NULL
L.	NULL
Avivi	NULL
,	NULL
and	NULL
Y.	NULL
Groner	NULL
.	NULL

1994	NULL
.	NULL

AML1	NULL
,	NULL
AML2	NULL
,	NULL
and	NULL
AML3	NULL
,	NULL
the	NULL
human	NULL
members	NULL
of	NULL
the	NULL
runt	NULL
domain	NULL
gene-family	NULL
:	NULL
cDNA	NULL
structure	NULL
,	NULL
expression	NULL
,	NULL
and	NULL
chromosomal	NULL
localization	NULL
.	NULL

Genomics	NULL
23:425-432	NULL
.	NULL

21	NULL
.	NULL

Lin	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
A.	NULL
Tarlé	NULL
,	NULL
A.	NULL
Hajra	NULL
,	NULL
D.	NULL
F.	NULL
Claxton	NULL
,	NULL
P.	NULL
Marlton	NULL
,	NULL
M.	NULL
Freedman	NULL
,	NULL
M.	NULL
J.	NULL
Siciliano	NULL
,	NULL
and	NULL
F.	NULL
S.	NULL
Collins	NULL
.	NULL

1993	NULL
.	NULL

Fusion	NULL
between	NULL
transcription	NULL
factor	NULL
CBFB/	NULL
PEBP2B	NULL
and	NULL
a	NULL
myosin	NULL
heavy	NULL
chain	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Science	NULL
261:1041-1044	NULL
.	NULL

22	NULL
.	NULL

LoSardo	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
A.	NULL
L.	NULL
Boral	NULL
,	NULL
and	NULL
J.	NULL
Lenz	NULL
.	NULL

1990	NULL
.	NULL

Relative	NULL
importance	NULL
of	NULL
elements	NULL
within	NULL
the	NULL
SL3-3	NULL
virus	NULL
enhancer	NULL
for	NULL
T-cell	NULL
specificity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1756-1763	NULL
.	NULL

23	NULL
.	NULL

Manley	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
M.	NULL
O'Connell	NULL
,	NULL
W.	NULL
Sun	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
and	NULL
N.	NULL
Hopkins	NULL
.	NULL

1993	NULL
.	NULL

Two	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
highly	NULL
conserved	NULL
sequences	NULL
in	NULL
mammalian	NULL
type	NULL
C	NULL
retroviral	NULL
enhancers	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:1967-1975	NULL
.	NULL

24	NULL
.	NULL

Melnikova	NULL
,	NULL
I.	NULL
N.	NULL
,	NULL
B.	NULL
E.	NULL
Crute	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Speck	NULL
.	NULL

1993	NULL
.	NULL

Sequence	NULL
specificity	NULL
of	NULL
the	NULL
core-binding	NULL
factor	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2408-2411	NULL
.	NULL

25	NULL
.	NULL

Meyers	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
R.	NULL
Downing	NULL
,	NULL
and	NULL
S.	NULL
W.	NULL
Hiebert	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
AML-1	NULL
and	NULL
the	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
translocation	NULL
protein	NULL
(	NULL
AML-1/ETO	NULL
)	NULL
as	NULL
sequence-specific	NULL
DNA-binding	NULL
proteins	NULL
:	NULL
the	NULL
runt	NULL
homology	NULL
domain	NULL
is	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:6336-6345	NULL
.	NULL

26	NULL
.	NULL

Mitani	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Ogawa	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
H.	NULL
Miyoshi	NULL
,	NULL
M.	NULL
Kurokawa	NULL
,	NULL
H.	NULL
Mano	NULL
,	NULL
Y.	NULL
Yazaki	NULL
,	NULL
M.	NULL
Ohki	NULL
,	NULL
and	NULL
H.	NULL
Hirai	NULL
.	NULL

1994	NULL
.	NULL

Generation	NULL
of	NULL
the	NULL
AML1-EVI-1	NULL
fusion	NULL
gene	NULL
in	NULL
the	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q26	NULL
;	NULL
q22	NULL
)	NULL
causes	NULL
blastic	NULL
crisis	NULL
in	NULL
chronic	NULL
myelocytic	NULL
leukemia	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:504-510	NULL
.	NULL

27	NULL
.	NULL

Miyoshi	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Kozu	NULL
,	NULL
K.	NULL
Shimizu	NULL
,	NULL
K.	NULL
Enomoto	NULL
,	NULL
N.	NULL
Maseki	NULL
,	NULL
Y.	NULL
Kaneko	NULL
,	NULL
N.	NULL
Kamada	NULL
,	NULL
and	NULL
M.	NULL
Ohki	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
translocation	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
results	NULL
in	NULL
production	NULL
of	NULL
an	NULL
AML1	NULL
-MTG8	NULL
fusion	NULL
transcript	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:2715-2721	NULL
.	NULL

28	NULL
.	NULL

Miyoshi	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Shimizu	NULL
,	NULL
T.	NULL
Kozu	NULL
,	NULL
N.	NULL
Maseki	NULL
,	NULL
Y.	NULL
Kaneko	NULL
,	NULL
and	NULL
M.	NULL
Ohki	NULL
.	NULL

1991.	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
breakpoints	NULL
on	NULL
chromosome	NULL
21	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
are	NULL
clustered	NULL
within	NULL
a	NULL
limited	NULL
region	NULL
of	NULL
a	NULL
single	NULL
gene	NULL
,	NULL
AMLJ	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:10431-10434	NULL
.	NULL

29	NULL
.	NULL

Morrison	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
B.	NULL
Soni	NULL
,	NULL
and	NULL
J.	NULL
Lenz	NULL
.	NULL

1995	NULL
.	NULL

Long	NULL
terminal	NULL
repeat	NULL
enhancer	NULL
core	NULL
sequences	NULL
in	NULL
proviruses	NULL
adjacent	NULL
to	NULL
c-myc	NULL
and	NULL
pim-1	NULL
in	NULL
T-cell	NULL
lymphomas	NULL
induced	NULL
by	NULL
a	NULL
murine	NULL
retrovirus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:446-455	NULL
.	NULL

30	NULL
.	NULL

Nucifora	NULL
,	NULL
G.	NULL
,	NULL
C.	NULL
R.	NULL
Begy	NULL
,	NULL
P.	NULL
Erickson	NULL
,	NULL
H.	NULL
A.	NULL
Drabkin	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Rowley	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
3	NULL
;	NULL
21	NULL
translocation	NULL
in	NULL
myelodysplasia	NULL
results	NULL
in	NULL
a	NULL
fusion	NULL
transcript	NULL
between	NULL
the	NULL
AMLI	NULL
gene	NULL
and	NULL
the	NULL
gene	NULL
for	NULL
EAP	NULL
,	NULL
a	NULL
highly	NULL
conserved	NULL
protein	NULL
associated	NULL
with	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
small	NULL
RNA	NULL
EBER	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:7784-7788	NULL
.	NULL

31	NULL
.	NULL

Nucifora	NULL
,	NULL
G.	NULL
,	NULL
D.	NULL
J.	NULL
Birn	NULL
,	NULL
R.	NULL
I.	NULL
Espinosa	NULL
,	NULL
M.	NULL
M.	NULL
LeBeau	NULL
,	NULL
D.	NULL
Roulston	NULL
,	NULL
T.	NULL
W.	NULL
McKeithan	NULL
,	NULL
H.	NULL
Drabkin	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Rowley	NULL
.	NULL

1993	NULL
.	NULL

Involvement	NULL
of	NULL
the	NULL
AML	NULL
]	NULL
gene	NULL
in	NULL
the	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
in	NULL
therapy-related	NULL
leukemia	NULL
and	NULL
in	NULL
chronic	NULL
myeloid	NULL
leukemia	NULL
in	NULL
blast	NULL
crisis	NULL
.	NULL

Blood	NULL
81:2728-2734	NULL
.	NULL

32	NULL
.	NULL

Nye	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
M.	NULL
Petersen	NULL
,	NULL
C.	NULL
V.	NULL
Gunther	NULL
,	NULL
M.	NULL
D.	NULL
Jonsen	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
of	NULL
murine	NULL
Ets-1	NULL
with	NULL
GGA-binding	NULL
sites	NULL
establishes	NULL
the	NULL
ETS	NULL
domain	NULL
as	NULL
a	NULL
new	NULL
DNA-binding	NULL
motif	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:975-990	NULL
.	NULL

33	NULL
.	NULL

Ogawa	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Inuzuka	NULL
,	NULL
M.	NULL
Maruyama	NULL
,	NULL
M.	NULL
Satake	NULL
,	NULL
M.	NULL
Fujimoto-Naito	NULL
,	NULL
Y.	NULL
Ito	NULL
,	NULL
and	NULL
K.	NULL
Shigesada	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
heterodimeric	NULL
partner	NULL
of	NULL
a	NULL
novel	NULL
Drosophila	NULL
runt-related	NULL
DNA	NULL
binding	NULL
protein	NULL
PEBP2	NULL
«	NULL
.	NULL

Virology	NULL
194:314-331	NULL
.	NULL

34	NULL
.	NULL

Ogawa	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Maruyama	NULL
,	NULL
H.	NULL
Kagoshima	NULL
,	NULL
M.	NULL
Inuzuka	NULL
,	NULL
J.	NULL
Lu	NULL
,	NULL
M.	NULL
Satake	NULL
,	NULL
K.	NULL
Shigesada	NULL
,	NULL
and	NULL
Y.	NULL
Ito	NULL
.	NULL

1993	NULL
.	NULL

PEBP2/PEA2	NULL
represents	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
homologous	NULL
to	NULL
the	NULL
products	NULL
of	NULL
the	NULL
Drosophile	NULL
runt	NULL
gene	NULL
and	NULL
the	NULL
human	NULL
AML1	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:6859-6863	NULL
.	NULL

35	NULL
.	NULL

Prosser	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
D.	NULL
Wotton	NULL
,	NULL
J.	NULL
Gegonne	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Owen	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
phorbol	NULL
ester	NULL
response	NULL
element	NULL
within	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
B-chain	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:9934-9938	NULL
.	NULL

36	NULL
.	NULL

Ptashne	NULL
,	NULL
M.	NULL
1988	NULL
.	NULL

How	NULL
eukaryotic	NULL
transcriptional	NULL
activators	NULL
work	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
335:683-689	NULL
.	NULL

37	NULL
.	NULL

Redondo	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
J.	NULL
L.	NULL
Pfohl	NULL
,	NULL
C.	NULL
Hernandez-Munain	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Krangel	NULL
.	NULL

1992	NULL
.	NULL

Indistinguishable	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
functional	NULL
core	NULL
sites	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
8	NULL
and	NULL
the	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancers	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4817-4823	NULL
.	NULL

2906	NULL
38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

ZAIMAN	NULL
ET	NULL
AL	NULL
.	NULL

Rubin	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
R.	NULL
A.	NULL
Larson	NULL
,	NULL
J.	NULL
Anastasi	NULL
,	NULL
J.	NULL
N.	NULL
Winter	NULL
,	NULL
M.	NULL
Thangavelu	NULL
,	NULL
J.	NULL
W.	NULL
Vardiman	NULL
,	NULL
J.	NULL
D.	NULL
Rowley	NULL
,	NULL
and	NULL
M.	NULL
M.	NULL
LeBeau	NULL
.	NULL

1990.	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q26	NULL
;	NULL
q22	NULL
)	NULL
:	NULL
a	NULL
recurring	NULL
chromosomal	NULL
abnormality	NULL
in	NULL
therapy-related	NULL
myelodysplastic	NULL
syndrome	NULL
and	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Blood	NULL
76:2594-2598	NULL
.	NULL

Satake	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Nomura	NULL
,	NULL
Y.	NULL
Y	NULL
:	NULL
guchi-Iwai	NULL
,	NULL
Y.	NULL
Takah	NULL
M.	NULL
Hashimoto	NULL
,	NULL
K.	NULL
Niki	NULL
,	NULL
K.	NULL
Yukihiko	NULL
,	NULL
and	NULL
Y.	NULL
Ito	NULL
.	NULL

1995	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
Runt	NULL
domain-encoding	NULL
PEBP2e	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
during	NULL
thymic	NULL
development	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
:	NULL
1662-1670	NULL
.	NULL

Short	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
S.	NULL
A.	NULL
Okengquist	NULL
,	NULL
and	NULL
J.	NULL
Lenz	NULL
.	NULL

1987	NULL
.	NULL

Correlation	NULL
of	NULL
leukemogenic	NULL
potential	NULL
of	NULL
murine	NULL
retroviruses	NULL
with	NULL
transcriptional	NULL
tissue	NULL
preference	NULL
of	NULL
the	NULL
viral	NULL
long	NULL
terminal	NULL
repeats	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:1067-1072	NULL
.	NULL

Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

Six	NULL
distinct	NULL
nuclear	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
75-base-pair	NULL
repeat	NULL
of	NULL
the	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:1101-1110	NULL
.	NULL

Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
B.	NULL
Renjifo	NULL
,	NULL
E.	NULL
Golemis	NULL
,	NULL
T.	NULL
Fredrickson	NULL
,	NULL
J.	NULL
Hartley	NULL
,	NULL
and	NULL
N.	NULL
Hopkins	NULL
.	NULL

1990	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
core	NULL
or	NULL
adjacent	NULL
LVb	NULL
elements	NULL
of	NULL
the	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancer	NULL
alters	NULL
disease	NULL
specificity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4233-242	NULL
.	NULL

Stafford	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
C.	NULL
Queen	NULL
.	NULL

1983	NULL
.	NULL

Cell-type	NULL
specific	NULL
expression	NULL
of	NULL
a	NULL
transfected	NULL
immunoglobulin	NULL
gene	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
306:77-79	NULL
.	NULL

Sun	NULL
,	NULL
W.	NULL
,	NULL
M.	NULL
O'Connell	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Speck	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
protein	NULL
that	NULL
binds	NULL
multiple	NULL
sequences	NULL
in	NULL
mammalian	NULL
type	NULL
C	NULL
retrovirus	NULL
enhancers	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:1976-1986	NULL
.	NULL

Suzow	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Friedman	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
murine	NULL
myeloperoxidase	NULL
promoter	NULL
contains	NULL
several	NULL
functional	NULL
elements	NULL
,	NULL
one	NULL
of	NULL
which	NULL
binds	NULL
a	NULL
cell	NULL
type-restricted	NULL
46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

transcription	NULL
factor	NULL
,	NULL
myeloid	NULL
nuclear	NULL
factor	NULL
1	NULL
(	NULL
MyNF1	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:2141-2151	NULL
.	NULL

Thornell	NULL
,	NULL
A.	NULL
,	NULL
B.	NULL
Hallberg	NULL
,	NULL
and	NULL
T.	NULL
Grundstrom	NULL
.	NULL

1988	NULL
.	NULL

Differential	NULL
protein	NULL
binding	NULL
in	NULL
lymphocytes	NULL
to	NULL
a	NULL
sequence	NULL
in	NULL
the	NULL
enhancer	NULL
of	NULL
the	NULL
mouse	NULL
retrovirus	NULL
SL3-3	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1625-1637	NULL
.	NULL

Thornell	NULL
,	NULL
A.	NULL
,	NULL
B.	NULL
Hallberg	NULL
,	NULL
and	NULL
T.	NULL
Grundstrom	NULL
.	NULL

1991	NULL
.	NULL

Binding	NULL
of	NULL
SL3-3	NULL
enhancer	NULL
factor	NULL
1	NULL
transcriptional	NULL
activators	NULL
to	NULL
viral	NULL
and	NULL
chromosomal	NULL
enhancer	NULL
sequences	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:42-50	NULL
.	NULL

Thornell	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Holm	NULL
,	NULL
and	NULL
T.	NULL
Grundstrom	NULL
.	NULL

1993	NULL
.	NULL

Purification	NULL
of	NULL
SEF1	NULL
proteins	NULL
binding	NULL
to	NULL
transcriptional	NULL
enhancer	NULL
elements	NULL
active	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:21946-21954	NULL
.	NULL

Wang	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Speck	NULL
.	NULL

1992	NULL
.	NULL

Purification	NULL
of	NULL
core-binding	NULL
factor	NULL
,	NULL
a	NULL
protein	NULL
that	NULL
binds	NULL
the	NULL
conserved	NULL
core	NULL
site	NULL
in	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancers	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:89-102	NULL
.	NULL

Wang	NULL
,	NULL
S.	NULL
,	NULL
Q.	NULL
Wang	NULL
,	NULL
B.	NULL
E.	NULL
Crute	NULL
,	NULL
I.	NULL
N.	NULL
Melnikova	NULL
,	NULL
S.	NULL
R.	NULL
Keller	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Speck	NULL
.	NULL

1993	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
subunits	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
and	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancer	NULL
core-binding	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3324-3339	NULL
.	NULL

Weiher	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Konig	NULL
,	NULL
and	NULL
P.	NULL
Gruss	NULL
.	NULL

1983	NULL
.	NULL

Multiple	NULL
point	NULL
mutations	NULL
affecting	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
enhancer	NULL
.	NULL

Science	NULL
219:626-631	NULL
.	NULL

Wijmenga	NULL
,	NULL
C.	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
N.	NULL
C.	NULL
Dracopoli	NULL
,	NULL
M.	NULL
H.	NULL
Hofker	NULL
,	NULL
P.	NULL
Liu	NULL
,	NULL
and	NULL
F.	NULL
S.	NULL
Collins	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
new	NULL
Runt-domain	NULL
containing	NULL
gene	NULL
Cbfo3	NULL
,	NULL
and	NULL
localization	NULL
of	NULL
the	NULL
human	NULL
homolog	NULL
CBFa3	NULL
,	NULL
to	NULL
chromosome	NULL
1p34	NULL
.	NULL

Genomics	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Zaiman	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
J.	NULL
Lenz	NULL
.	NULL

1995	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

